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blood see also cord blood 
erythrocytes, plasma, serum 
- , coagulation 744 
— , reference material 744 
-,.ethanol 722 
- - , microdetermination 722 
- , glucose 129, 149, 255, 275, 
885 
— , determination 129, 885 
, and deproteinization 
129 
- , men 897 
— , Cortisol 897 
, after rifampicin 897 
, after streptomycin 897 
- - , testosterone 897 
, after rifampicin 897 
, after streptomycin 897 
- , occult 695 
— , faeces 695 
- , phenylpyruvic acid 755 
- , thyrotropin 807 
— , screening 807 
blood/brain barrier 
- , dysfunction 717 
— , IgG 717 
blood gases 829 
blood group 4, 383 
bone 
- , biopsy 403 
— , aluminium 403 
— , phosphorus 403 
brain 
- , acute damage 668 
— , creatine kinase-BB 668 




- , receptor assay 727, 728, 
729 
bupivacaine 
- , plasma 351 
- - , gas chromatography 351 
C-peptide 
- , plasma 313 
- , urine 313 
C-reactive protein 
- , determination 710 
CI esterase 
- , inhibitor 17 
- - , assay 17 
, hereditary angio-
neurotic edema 17 
— , inhibition mechanism 17 
-, Michaelis constant 
Ca2+-paradox 
- , enzyme release 674 
— , by rat heart 674 
calcitonin 
- , assay 664 
- , serum 747 
— , neonates 747 
— , pregnancy 747 
calibration 855 
cAMP 
- , plasma 909 
- - , after glucagon 909 
~, radioimmunoassay 732 
— , inhibition by EDTA 732 
- , receptors 656 
— , tissue 656 
, malignant 656 
cancer 
- , polyamines 698 
— , urine 698 
cancer therapy 
- , monitoring 763 
Carbamazepin 
serum 227 
— , determination 227 
carbohydrates 
- , content 31 
— , glycoproteins 31 
carbon dioxide 
- , partial pressure 829 
carbon tetrachloride 




- , adenocarcinoma 175 
— , gastrointestinal tract 175 
- , immune complexes 175 
carcinogenesis 
- , steroid epoxides 937 
catabolism 
- , enzymes 679 
catalase 
- , erythrocytes 771 
— , cord blood 771 
— , maternal 771 
catecholamines 
- , circadian rhythm 735 
— , apallic syndrome 735 
conjugated 431 
- - , plasma 431 
, determination 431 
- , methylation 413 
— , enzymatic 413 
- , plasma 413 
response 367 
— , to exercise 367 
urine 567 
catechol-O-methyltransferase 
breast tissue 763 
- , radioenzymatic assay 672 
- - , hair root cells 672 
CEA 175, 821 
cefotaxime 
- , serum 719 
— , determination 719 
, by HPLC719 
- , urine 719 
— , determination 719 
,by HPLC719 
cerebrospinal fluid 
- , albumin 245 
- , circulation 746 
— , prealbumin as indicator 
746 
- , cisternal 745 
— , glucose 745 
- , diagnosis 7 
— , with rapid tests 7 
- , fibronectin 797 
- , glucose 129, 275 
— , determination 129 
, and deproteinization 129 
-> IgA 245 
- , IgG 245 
- , IgM 245 
- , lactate 746 
— , meningitis purulenta 746 
- , lumbar 745 
— , glucose 745 
- , a:2-macrogIobulin 671 
- , peptide hormones 731 
- - , separation 731 
- , prealbumin 245 
- , production 746 
— , prealbumin as indicator 
746 
- , protein pattern 23 
— , Polyacrylamide gel 
electrophoresis 23 
, sample preparation 23 
cerebrospinal fluid 
proteins 7, 123 
— , adsorption 7 
, to reaction vessels 7 
— , nephelometry 123 
- , ventricular 745 
— , glucose 745 
circadian rhythm see also 
variation 
- , catecholamines 735 
— , apallic syndrome 735 
cisplatin 
- , leukemia treatment 690 
— , ATP 690 
- , therapy 687 
— , N-acetyl-0-D-glucos-
aminidase 687 
, urine 687 
— , alanine aminopeptidase 
687 
, urine 687 
Chagas disease 
- , trypanosomes 383 
— , characterization 383 
, by lectins 383 
chenodeoxycholic acid 
- , serum 491 
— , radioimmunoassay 491 
children 
- , reference values 713 
—,copper 713 
, serum 713 
, urine 713 
— , zinc 713 
, serum 713 
, urine 713 
chloride 
- , urine 703 
cholestasis 
extrahepatic 111 
— , and protein phosphoryla-
tion 111 
cholesterol see also HDL, 
LDL 
- , method comparison 595,752 
cholesterolesterase 
- , specificity 595 
cholesteryl esters 
- , hydrolysis 595 
cholic acid 
- , serum 491 
— , radioimmunoassay 491 
chorionic gonadotropin 
- , adenylate cyclase 747 
— , liver, foetal 747 
- , determination 733 
0-chorionic gonadotropin 821 
Chromate 
- , tubular damage 686 
chromatography see high per-
formance liquid, ion ex-
change, thin layer 
chromogenic substrates 631 
chromogenic substrate S-2444 
557 
Chromozyms 709 
Chromozym TRY 671 
chymotrypsin 
- , faeces 695 
— , determination 695 
clearance 
creatinine 423 
— , variation 423 
- , urea 423 
— , variation 423 
clinical chemistry 
- , perspectives 453, 455 
— , automatization 455 
- , postgraduate course 439 
clobazepam 
- , serum 209 
— , determination 209 
- , urine 209 
— , determination 209 
clotting tests see also coagula-
tion 
- , and glycerophosphatides 
711 
coagulation see also clotting 
- , determination 659, 709,710 
— , chromogenic substrate 
659 
- - , non-carboxylated factors 
710 
- , reference material 744 
coagulation system 
- , plasmatic 545 
— , and thromboplastic 
activity 545 
, of arterial walls 545 
cold agglutinins 
- , monoclonal 716 
— , for glycoconjugate-asso-
ciated antigens 716 
, neoplastic cells 716 
cold insoluble globulin 
- , laser nephelometry 702 
collagen 
- , metabolism 287 
— , protein malnutrition 287 
colloid osmotic pressure 
- , plasma 233 
- - , determination 233 
competitive protein binding 
assay 
- , progesterone 355 
complement 17 
computer processing 
- , radioimmunoassay data 660 
computer programme 
- , HP 97 215 
— , radioimmunoassay 215 
confidence intervals 
- , radioimmunoassay 879 
consensus value 461 
control materials 855 
control specimens 
- , assigned values 461 
— , determination 461 
copper 
- , excretion 713 
— , in rat bile 713 
, and glutathione deple-
tion 713 
, and paracetamol 713 
, and penicillamine 713 
- , serum 712 
- - , determination 712 
, atomic absorption 
spectrometry 712 
, reference values 713 
, children 713 
- , urine 713 
— , reference values 713 
, children 713 
cord blood see also erythro-
cytes 
- , creatine kinase 675 
—, Duchenne muscular 
dystrophy 675 
corticosteroid 
- , binding globulin 137 
- - , binding capacity 137 
, in liver cirrhosis 137 
corticotropin 
- , plasma 740 
- - , circadian variation 740 
episodic variation 740 
Cortisol 
blood 897 
— , of men 897 
, after rifampicin 897 
, after streptomycin 897 
- , plasma 740 
— , diurnal variation 740 
- , serum 183, 867 
— , after insulin 867 
— , after thyroliberin 867 
— , quality control survey 
183 
coumarol 
- , treatment 709 
— , monitoring 709 
counting 
- , leukocytes 691 
covariance selection 743 
craniocerebral damage 
creatine kinase 676 
— , isoenzymes 676 
creatine kinase 
- , isoenzymes 676 
— , craniocerebral damage 
676 
- , mitochondrial 679 
— , radioimmunoassay 679 
- , serum 675 
—, Duchenne muscular 
dystrophy 675 
creatine kinase-B 
- , radioimmunoassay 678, 
679 
creatine kinase-BB 
- , acute brain damage 668 
- , macro form 677, 678 
— , binding site 677, 678 
, IgG 677, 678 
creatine kinase-MB 
- , acute myocardial infarc-
tion 676 
- , determination 679 
- , fractionation 678 
creatinine 
- , clearance 423 
— , variation 423 
- , physical exercise 651 
- , serum 423 
— , variation 423 
- , true 385 
— , serum 385 
— , urine 385 
- , urine 423, 705 
— , variation 423 
curve-fitting methods 105, 
197 
cuvette 
- , specifications 445 
— , listing 445 
cystine aminopeptidase 
- , placenta 631 
cystinuria 
- , screening 303 
cytarabin 
- , leukaemia treatment 690 
— , ATP 690 
dacarbazin 
- , leukemia treatment 690 
— , ATP 690 
data 
handling 947 
- , structure 461 
— , from different labora-
tories 461 
definitive value 461 
dehydroepiandrosterone 
- , metabolism 747 
— , placenta 747 
dehydroepiandrosterone 
- , plasma 117 
— , determination 117 
urine 741 
— , determination 741 
delipidation 
- , serum 917 
density 
- , measurement 233 
— , by mechanical oscillator 
technique 233 
plasma 615 
— , measurement 615 





— , urine 579 
depressive syndrome 
function test 867 
— , neuroendocrine 867 
desacetylcefotaxime 
serum 719 
— , determination 719 
, by HPLC719 
urine 719 
— , determination 719 
, by HPLC719 
detectability 78 
diabetes 
- , glycosaminoglycan, novel 
672 
lipoproteins 752 
- - , carbohydrate content 
752 
- , rat 901 
diabetogenic action 
thyroid hormone 738 
diagnostic significance 
tumour marker 821 
dialysis 
- , and lipoproteins 751 
diethylstilboestrol 
receptor binding 729 
differentiation 





- , enzyme release 674 
— , by rat heart 674 
5a-dihydrotestosterone 
- , and sex-hormone binding 
globulin 730 
2,4-dinitrophenol 
- , enzyme release 674 
— , by rat heart 674 
disc electrophoresis 
- , proteins 53 
— , urine 53 
, value, diagnostic 53 
diurnal variation see also 
variation 
- , prostatic acid phosphatase 
297 
dopamine 
- , plasma 367, 413 
— , exercise 367 
- - , radioenzymatic assay 
367 
doxorubicin 
- , leukaemia treatment 690 
— , ATP 690 
drugs 
- , and alcohol 721 
- , interference 385 
Duchenne muscular dystrophy 
- , creatine kinase 675 
— , cord blood 675 
— , serum 675 
Dyggve-Melchior-Clausen syn-
drome 
- , a2-macroglobulin 67 
— , serum 67 
ECCLS 
- , byelaws 637 
— , revised 637 
edema 
- , hereditary angioneurotic 17 
EDTA 
- , lead elimination 163 
elastase 
- , leukocyte 699 
— , determination 699 
electroimmunoassay 
- , apolipoprotein A-I 917 
- , apolipoprotein A-II 917 
elimination 
- , lead 163 
emergency analyses 693 
emergency laboratory 
- , information system 39 
emission spectral analysis 
- , aluminium 591 
EMIT 
- , methotrexate 169 
encephalitis 
- , viral 717 
— , IgG 717 
encephalomyelitis 
- , experimental allergic 1 
endometrium 
- , steroid receptors 654 
endotoxaemia 
- , proteases 671 
— , and protease inhibitors 
671 
enzyme 
- , activities 649 
— , physical exercise 649 
, extracellular fluid 649 
enzyme immunoassay 
- , antiepileptics 720 
- , heterogeneous 197 
- , homogeneous 197 
- , hormone determination 
662 
- , marker enzymes 197 
- , mechanization 197 
- , methotrexate 169 
- , oestradiol-170 664 
- , oestrogens 327, 735 
- , placental lactogen 735 
- , pregnancy-specific 
-glycoprotein 710 
- , reliability 197 
— , criteria of 197 
- , testosterone 661 
- , triiodothyronine 718 
enzyme linked immuno-
sorbent assay 
- , peroxidase assay 345 
enzymes 
- , catabolism 679 
— , two-compartment model 
679 
- , cellular 666 
— , in extracellular space 666 
- , determination 89 
— , IFCC methods 89 
- , differentiation 379 
— , by lectins 379 
- , elimination 666 
enzymes 
- , glycosaminoglycan 
depolymerizing 672 
— , scoliotic children 672 
- , markers 197 
— , enzyme immunoassay 197 
- , release 674 
— , rat heart 674 
, by Ca2+-paradox 674 
, by digitonin 674 
, by 2,4-dinitrophenol 
674 
- , urine 686 
- - , kidney damage 686 
enzyme tests 
- , risk populations 763 
— , identification 763 
epidural analgesia 
bupivacaine 351 
— , determination 351 
epinephrine 
- , plasma 367,413 
— , exercise 367 
— , radioenzymatic assay 367 
epoxide hydrolase 775 
epoxides 
- , steroids 937 








- , differentiation 433 
erythrocytes see also blood, 
cord blood 
- , cerebrospinal fluid 7 
- , cord blood 771 
— , catalase 771 
— , glutathione peroxidase 
771 
— , superoxide dismutase 771 
- , magnesium 257 
- , maternal 771 
— , catalase 771 
— , glutathione peroxidase 
771 
— , superoxide dismutase 
771 
- , membrane 377 
— , glycoproteins 377 
- , oxygen dissociation curves 
689 
- , reference values 621 




- , microdetermination 722 
ethosuximide 
- , serum 339 




- , instruments 693 
— , principles 693 
excretion 
- , magnesium 257 
exercise 
- , catecholamine response 
367 
- , physical 649, 651, 652, 
707, 708 
— , enzyme activities 649 
, extracellular fluid 649 
— , HDL-cholesterol 707 
exercise 
- , physical 
— , lactate 652 
, formation kinetics 652 
- - , lipid metabolism 708 
, in insulin deficiency 708 
— , lipoproteins 652 
- - , metabolism 651 
— , somatotropin release 708 
, in pancreatectomized 
men 708 
- , renin 367 
extracellular fluid 
- , enzyme activities 649 
— , physical exercise 649 
extracellular space 
- , enzymes 666 
— , cellular 666 
extraction 
- , bupivicaine 351 
- , catecholamines 367 
- , steroids 355 
F-CB3 
- , radioimmunoassay 711 
factor VNI-related antigen 
- , radioimmunoassay 711 
faeces 
- , blood 695 
— , occult 695 
- , chymotrypin 695 
fast red TR 603 
fenoterol 
- , and hormones in pregnancy 
748 






- , determination 659 
— , chromogenic substrates 
659 
- , regulation 657 
fibronectin 
- , body fluids 702, 797 
— , laser nephelometry 702, 
797 
- , plasma 893 
- - , laser nephelometry 893 
— , liver diseases 893 
fibrinopeptide-A 
- , radioimmunoassay 711 
fibroblasts 
- , alcohol dehydrogenase 699 
- , aldehyde dehydrogenase 
699 
flow diagram 
- , 5'-nucleotidase 333 
uric acid 363 
fluorometry 
- , clobazepam 209 
fluoro uracil 
- , leukaemia treatment 690 
— , ATP 690 
a-foetoprotein 821 
- , particle counting immuno-
assay 701 
folate 
binding 715, 716 
— , to cow's milk protein 715 
— , to leukaemia serum pro-
tein 716 
Friedewald formula 751 
fucosyltransferase 
- , serum 670 




— , for affective diseases 867 
galactans 
- , and lectins 376 
galactosyltransferase I I 
tumour marker 763 
gas chromatography 
- , antiepileptics 720 
antipyrine® 817 
- , bupivacaine 351 
- , Carbamazepin 227 
clobazepam 209 
- , ethosuximide 339 
- , 3-methoxy-4-hydroxy-
phenylglycol 579 
- , Phenazone 817 
- , phenobarbital 227 
- , Phenytoin 227 
primidone 227 
valproic acid 339, 497 
gestosis 
- , uric acid 749 
glomerula 
- , kidney 901 
— , isolated 901 
, metabolism 901 
, and insulin 901 
glucagon 
- , and cAMP 909 
— , plasma 909 
glucose 
- , bivariate reference range 
745 
— , CSF/serum 745 
- , blood 129, 149, 255, 275 
— , determination 255, 275 
, kinetic 275 
— , and deproteinization 129 
- , cerebrospinal fluid 275, 
745 
— , cisternal 745 
— , determination 275 
, kinetic 275 
— , lumbar 745 
— , ventricular 745 
- , determination 885 
— , blood 885 
, hemolysed 885 
- , metabolism 901 
— , glomerula 901 
- , monitoring 732 
- , serum 49, 867 
— , after insulin 867 
— , after thyroliberin 867 
— , kinetic determination 49 
, hexokinase method 49 
- , urine 275, 703 
— , determination 275 
, kinetic 275 
glucose dehydrogenase 




- , inhibition 49 
— , competitive 49 
/3-glucuronidase 
- , amniotic fluid 611 
— , and sex of the child 611 
glucuronidation 307 
7-glutamyltransferase 
- , histochemistry 237 
- , isoenzymes 673 
- , liver 237 
— , and ethanol 237 
- , plasma 237 
— , and ethanol 237 
glutathione 
- , depletion 713 
— , copper excretion 713 
— , zinc excretion 713 
glutathione peroxidase 
- , erythrocytes 771 
— , cord blood 771 
— , maternal 771 
glutathione reductase 
- , receptor model 724 
goitre 909 
granulocyte 
- , migration 723 
— , and bee venom peptides 
723 
guaiac test 695 
glycerol-2-phosphate 
- , inhibitor 781 
— , 5'-nucleotidase 781 
glycerophosphatides 
- , and clotting tests 711 
- , determination 711 
— , enzymatic 711 
glycine 
- , bile acid conjugation 407 
— , colorimetry 407 
glycoconjugate-associated 
antigens 
- , neoplastic cells 716 
— , and monoclonal cold 
agglutinins 716 
glycoproteins 
- , carbohydrate content 31 
- , desialylated 31 
—,fate 31 
, in mouse circulation 
31 
- , erythrocyte membrane 377 
- , interaction 379 
— , lectins 379 
- , lymphocyte membrane 377 
glycosaminoglycan 
- , novel 672 
— , in diabetics 672 
glycosaminoglycans 
- , depolymerizing enzymes 
672 
— , scoliotic children 672 
- , rat 279 
— , liver 279 
— , serum 279 
haematin D-575 689 
haematocrit 
- , fenoterol 687 
- , reference values 621 
- , verapamil 687 
haematology 
- , quality control 649 
- , spin label method 648 
haemodialysis 
- , ax-antitrypsin 241 
— , serum 241 
haemoglobin 
- , determination 689 
— , by alkaline haematin 
D-575 689 
- , fenoterol 687 
- , glycosylated 686 
— , chronic renal failure 686 
- , reference values 621 
- , verapamil 687 
haemolysate 
- , glucose 885 
haemolysis 
- , interference 615 
— , density measurement 615 
- reagent 255, 885 
hae mo stasis 545 
haemolyzing agent 255, 885 
hair roots 
- , alcohol dehydrogenase 699 





- , determination 705 
- , exercise, physical 707 
- , method comparison 752 
- , plasma 737 
- - , and thyroid state 737 
- , and pseudoCholinesterase 
684 
HDL 
- , apoIipoprotein-A 917 
heart 
- , coronary disease 749 
— , lipoproteins 749 
- , magnesium 257 
- , rat 674 
— , enzyme release 674 
, by Ca2+-paradox 674 
, by digitonin 674 
, by 2,4-dinitrophenol 
674 
nemo- see haemoT 
heparin 
- , action 710 
- , plasma 658 
— , determination 658 
, clinical relevance 658 
hepatic fibrosis 921 
hereditary angioneurotic edema 
17 
heterogeneity 
- , ai-antitrypsin 13 
high density lipoproteins 917 
high performance liquid 
chromatography 
- , aldosterone 742 
- , cefotaxime 719 
- , dehydroepiandrosterone 
741 
desacetylcefotaxime 719 
- , 18-hydroxycorticosterone 
742 
- , testosterone 741 
- , uric acid 702 
high voltage electrophoresis 
- , poly amines 698 
histochemistry 
- , 7-glutamyltransferase 237 
hormone 
- , determination 662 
— , enzyme immunoassay 
662 
hydrogen ion activity 829 
18-hydroxycorticosterone 
- , urine 742 
— , high performance liquid 
chromatography 742 
— , radioimmunoassay 742 
hydroxylysyl glycosides 




- , bezafibrate therapy 750 





- , stimulation 867 
hypothyroidism 909 
- , congenital 755, 807 
- - , screening 755, 807 
hypoxanthine phosphoribosyl-
transferase 
- , variants 754 
ICP-spectroscopy 591 
IgA 
- , cerebrospinal fluid 7, 245 
— , determination 245 
IgE 
- , serum 145 
- - , method comparison 145 
IgG 
- , cerebrospinal fluid 7, 245 
— , determination 245 
- , creatine kinase binding 677, 
678 
- , neurological diseases 717 
- , particle counting immuno-
assay 701 
- , protein-A binding 677 
- , turbidimetric assay 501 
IgM 
- , cerebrospinal fluid 245 
— , determination 245 
immune complex-like material 
- , liver cirrhosis 717 
- , septicaemia 717 
immunoglobulins 
- , serum 718 
— , determination 718 
immunohistochemistry 
- , parathyrin 739 
immunoturbidimetry 
- , protein determination 501 
- - , measuring time interval 
501 
- - , reaction medium 501 
imprecision 433 
indometacin 
- , and purine metabolism 754 
indoxylphosphate 
- , substrate 682 
- - , phosphatase, acid 682 
information system 
- , emergency laboratory 39 
inhibition 
- , arylesterase 683 
- - , by lanthanum 683 
- , glucose-6-phosphate dehy-
drogenase 49 
— , b y ATP 49 
inhibitors 
- , N-acetyl neuraminic acid 
708 
- - , of thromboxane synthesis 
708 
- , CI esterase 17 
- , monoamine oxidase 921 
- - , j3-aminopropionitrile 921 
- , 5'-nucleotidase 781 
- , sialyltransferase 271 
instruments 
- , evaluation principles 693 
- , specifications 947 
insulin 
- , antibodies 313 
- , deficiency 708 
— , lipid metabolism 708 
, and physical exercise 
708 
- , magnesium metabolism 257 
- , metabolic activity 901 
— , glomerula 901 
, isolated 901 
- , monitoring 732 
- , neuroendocrine function 
test 867 
- , plasma 313 
- , urine 313 
interferences 
- , by drugs 385 
- , gas chromatography 339 
— , ethosuximide 339 
— , valproate 339 
- , haemoglobin 615 
— , density measurement 615 
- , proteins 697 
— , by dextran 697 
- , sialyltransferase assay 271 
sucrose 23 
— , protein pattern 23 
- , turbidity 149 
- , uric acid assay 59, 363 
— , by ascorbate 363 
interleukin-2 inducing protein 
716 
intestine 
- , magnesium 257 
ion exchange chromatography 
- , catecholamine derivatives 
567 
— , of o-phthalaldehyde 567 
- , orotic acid 293 
- , polyamines 157 
iron 
- , plasma 714 
— , method comparison 714 
- , serum 147 
— , method comparison 147 
isoelectric focussing 
- , enzymes 631 
— , placental 631 
- , Polyacrylamide gel 13 
— , protein separation 13 
, effect of urea 13 
- , transferrins 563 
isoenzymes 
- , amylase 669, 673, 680, 
681 
- - , method comparison 681 
- , creatine kinase 676, 677, 
678,679 
- , 7-glutamyltransferase 673 
- , lactate dehydrogenase 675 
isotachophoresis 
ascorbic acid 715 
17-ketosteroids 741 
kidney 
- , chronic failure 686, 751 
- - , haemoglobin 686 
, glycosylated 686 
— , and lipoproteins 751 
- , damage 686 
— , enzymes 686 
, urine 686 
- , function 551 
- - , and pancreatic function 
test 551 
- , glomerula 901 
— , isolated 901 
, metabolism 901 
, and insulin 901 
- , lesion 378 
— , by neuraminidase 378 
- , magnesium 257 
- , maltase 685 
-, Tarnm-Horsfall glyco-
protein 376 
- - , characterization 376 
- , transplantation 241, 688 
—, a. i -antitrypsin 241 
, serum 241 
— , pepsinogens 688 
, serum 688 
kinetic method 
- , urea 706 
kallikrein 
- , urine 395 
— , radioimmunoassay 395 
lactate 
- , cerebrospinal fluid 746 
— , meningitis purulenta 746 
- , physical exercise 652 
lactate dehydrogenase 
- , isoenzyme, sixth 675 
— , in cardiogenic shock 675 
- , reference values 305 
— , age dependency 305 
lanthanum 
- , arylesterase inhibition 683 
laser nephelometry 221, 245 
- , fibronectin 702, 797, 893 
- , lectin-glycoprotein inter-
action 379 
LDL-cholesterol 
-, Friedewald formula 751 
- , method comparison 752 
- , significance 751 
lead 
- , elimination 163 
lectin 
- , receptors 377, 384 
- - , leukemia cells 377 
- - , mammary gland 384 
- , sponge 380 
- - , function 380 
lectins 
- , affinity chromatography 
381 
- , definition 373 
- , enzyme differentiation 379 
- , galactose specific 376 
— , and galactans 376 
- , interaction 379 
glycoproteins 379 
- , invertebrates 373 
- , plants 373 
- , protein binding 382 
- , receptors 380 
— , plexus chorioideus 380 
- , specificity 373 
- , structure 382 
- , trypanosome characteriza-
tion 383 
- , vertebrates 373 
Lesch-Nyhan syndrome 
- , fibroblasts 754 
— , metabolism 754 
leukaemia 
- , cells 377,655,690 
— , ATP 690 
, and cytotoxic sub-
stances 690 
— , glucocorticoid receptors 
655 
— , lectin receptors 377 
- , serum 716 
— , folate binding 716 
leukocytes 
- , cerebrospinal fluid 7 
- , counting 691 
^differentiation 647, 691, 
692 
- , elastase 699 
- , reference values 621 
lipids 
- , metabolism 708 
- - , in insulin deficiency 708 
, and physical exercise 
708 
lipoprotein lipase 753 
lipoprotein X 
- , catabolism 754 
lipoproteins see also HDL, 
LDL, VLDL 
- , carbohydrate content 752 
- , and dialysis 751 
- , method comparison 753 
- , physical exercise 652 
- , serum 749 
— , coronary heart disease 
749 
/Mipotropin 
- , preparation 736 
- , determination 736 
lithium 
- , therapy 867 
- - , depressive patients 867 
liver 
- , carbon tetrachloride poi-
soning 111 
- , cell injury 684 
- - , proteoglycan synthesis 
684 
- , cirrhosis 137, 717 
— , corticosteroid binding 
globulin 137 
— , immune complex-like 
material 717 
— , sex hormone binding 
globulin 137 
- , chronic diseases 737 
- - , sex hormones 737 
- - , thyroid hormones 737 
- , diseases 893 
— , fibronectin 893 
fibrosis 921 
— , and monoamine oxidase 
921 
, serum 921 
- , foetal 748 
— , adenylate cyclase 748 
, and chorionic gonado-
tropin 748 
- , 7-glutamyltransferase 237 
- - , and ethanol 237 
- , glycosaminoglycans 279 
- , injury 111, 279 
- - , proteins 111 
, ribosomal 111 
—,rat 279 
- , magnesium 257 
logit transformation 105 
lung 
- , diseases 13 
—, a i -antitrypsin 13 
- , maturity 749 
lymph nodes 
- , magnesium 257 
lymphocytes 
- , membrane 377 
— , glycoproteins 377 
lysozyme 694 
macro creatine kinase 677, 678 
a2-macroglobulin 
- , chromogenic assay 671 
- , plasma 221 
— , determination 221 
- , serum 67 
- -, Dyggve-Melchior-Oausen 
syndrome 67 
- , serum/CSF gradient 671 
magnesium 
- , analysis 257 
- , biochemical functions 257 
- , distribution 257 
— , extra-/intracellular 257 
— , hormonal regulation 257 
— , organelles 257 
- , excretion 257 
- , human body 257 
magnesium 
- , organs 257 
- , physico-chemical state 257 
— , extra-/intraceliular 257 
- - , organelles 257 
- , plasma 257 
- , resorption 257 
- , serum 257 




- , determination 685 
— , kidney preparation 685 
— , urine 685 
mammary carcinoma 
- , oestrogen receptors 653 
mammary gland 
- , lectin receptors 384 
malnutrition 
- , protein 287 
— , collagen metabolites 287 
, urine 287 
mass spectrometry 
- , steroid epoxides 937 
mast cell degranulating peptide 
- , membrane interaction 723 
matrix effects 




- , reference values 621 
MCHC 
- , reference values 621 
MCV 
reference values 621 
mechanical oscillator technique 
- , density 233 
— , measurement of 233 
mechanization 
- , definition 455 
- , enzyme immunoassay 197 
medroxyprogesterone 
- , receptor binding 729 
melanoma 
- , steroid binding 724 
melatonin 




- , interaction 723 
— , of mast cell degranulating 
peptide 723 
meningitis purulenta 
- , lactate 746 
— , cerebrospinal fluid 746 
mercury 
- , determination 714 
— , atomic absorption 
spectrometry 714 
metabolism 
- , physical exercise 651 
metanephrine 




- , schizophrenia 763 
method comparison 
- , amylase isoenzymes 681 
- , blood alcohol 721 
- , cholesterol 595, 752 
IgE 145 
- , iron 147, 714 
- , lipoproteins 753 
- , oestrogens 731 
- , phosphatase, acid 681 
method comparison 
protein, total 697 
- , statistical problems 433 
- , thyrotropin 807 
— , radioimmunoassay 807 
- , uric acid 702 
method dependence 
- , assigned values 461 
- , precision 461 
method description 78 
methotrexate 
- , serum 169 




- , urine 579 
— , gas chromatography 579 
3-methoxytyramine 
- , thin-layer chromato-
graphy 413 
Nl-methyl adenosine 
- , urine 696 
— , determination 696 
methylation 
- , enzymatic 413 
— , catecholamines 413 
N7-methyl guanosine 
- , urine 696 
— , determination 696 
3N-methylhistidine 
- , urine 756 
— , and muscle catabolism 
756 
5-methyltetrahydrofolate 
- , binding 715 
- - , to cow's milk protein 715 
methyltrienolone 
- , receptor binding 729 
Michaelis constant 
- , CI esterase 17 
mitochondria 
- , creatine kinase 679 
monoamine oxidase 
- , determination 921 
— , serum 921 
, in hepatic fibrosis 921 
- , inhibition 921 
— , by 0-aminopropionitrile 
921 
- , schizophrenia 763 
morbus Crohn 





- , catabolism 755 
— , 3N-methyihistidine 755 
, urine 755 
- , magnesium 257 
myelin basic protein 
- , enzyme immunoassay 345 
myocardial infarction 
- , creatine kinase-MB 676 




- , coupling 603 
— , with fast red TR 603 
neonates 
- , bilirubin 27 
— , serum 27 
, survey report 27 
- , calcitonin 747 
parathyrin 747 
neoplastic cells 
- , glycoconjugate-associated 
antigens 716 
— , and monoclonal cold 
agglutinins 716 
nephelometry 
- , laser 221 
— , Q!2 _ a n tipl asmin 221 
— , antithrombin I I I 221 
— , a2-macroglobulin 221 
- , proteins 123, 245 
— , cerebrospinal fluid 123, 
245 
nephrotic syndrome 381 
neuraminidase 
- , kidney lesion 378 
neurophysins 
- , preparation 736 
neurosyphilis 
- IgG 717 
neutron activation analysis 
—, aluminium 403 
- , phosphorus 403 
nickel 
- , inhibitor 781 




plasma 367, 413 
— , exercise 367 
— , radioenzymatic assay 367 
normal range 
- , corticosteroid binding 
globulin 137 
- , sex hormone binding 
globulin 137 
normetanephrine 
- , thin-layer chromato-
graphy 413 
nucleic acids 
- , metabolism 901 
— , glomerula 901 
5'-nucleotidase 
- , inhibitors 781 
- , spectrophotometric assay 
781 
- , serum 333 
— , AutoAnalyzer I I 333 
oestradiol 
- , and sex-hormone binding 
globulin 730 
oestradiol-17/3 




- , pregnancy 748 
oestrogens 
binding 724 
— , melanoma 724 
- , enzyme immunoassay 735 
- , receptor 653, 728 
— , capacity modulation 728 
, by phosphatidyl choline 
728 
— , melanoma 653 
- , serum 327 
— , total 327 
, enzyme immunoassay 
327 
- , urine 731 
— , method comparison 731 
oligosaccharides 
- , affinity chromatography 381 
separation 381 
organization 
- , laboratory 455 
organ preservation 
- , heavy water 747 
organs 
- , alcohol dehydrogenase 699 
- , aldehyde dehydrogenase 
699 
ornithine transcarbamylase 
- , deficiency 293 
orotic acid 
- , urine 293 
— , determination 293 
oscillator technique 
- , density measurement 615 
osmolality 829 
osmotic concentration 829 
outliers 
- , recognition 433 
oxygen 
- , dissociation curves 689 
— , determination 689 
- , half saturation pressure 
690 
— , determination 690 
- , partial pressure 829 
palmitic acid 
- , free 193 
— , in bile 193 
pancreas 
- , diseases 763 
— , trypsin 763 
- , function test 551 
— , oral 551 
, N-benzoyl-L-tyrosyl-p-
aminobenzoic acid 551 
, and renal function 551 
pancreatectomy 
- , and somatotropin release 
708 
— , physical exercise 708 
paracetamol 
- , copper excretion 713 
- , zinc excretion 713 
parathyrin 
- , adsorption on surfaces 595 
- , assay 664 
- , localization 739 
— , immunohistochemical 
739 
- , magnesium metabolism 257 
- , radioimmunoassay 739, 
789 
— , homologous 789 
— , influence of the tracer 
739 
- , serum 747 
— , neonates 747 
— , pregnancy 747 
particle counting immuno-
assay 
- , proteins 701 
- , thyroxine 701 
PCV 
reference values 621 
penicillamine 
- , copper excretion 713 
- , zinc excretion 713 
pepsinogens 
- , serum 688, 700 
— , radioimmunoassay 688, 
700 
peptide hormones 
- , reversed-phase chromato-
graphy 731 
peptides 
- , bee venom 723 
— , and granulocyte migra-
tion 723 
perfusion 
- , placenta 747 
— , dehydroepiandrosterone 
metabolism 747 
peroxidase 
- , assay 345 
— , enzyme immunosorbent 
assay 345 
pH 829 
phage test 1 
Phenazone 
- , plasma 817 
— , gas chromatography 817 
phenobarbital 
- , serum 227 
— , determination 227 
phenylalanine 
- , metabolism 755 
— , pregnancy 755 
phenylketonuria 755 
phenylpyruvic acid 
- , blood 755 
Phenytoin 
- , serum 227 
— , determination 227 
phosphatase, acid 
- , determination 603 
— , continuous 603 
- , prostate 669, 681, 682 
— , method comparison 681 
- , prostate carcinoma 297 
- , prostatic 627 
— , determination 627 
phosphatase, alkaline 
- , stabilization 698 
phosphatidyl choline 
- , oestrogen receptor 728 
— , capacity modulation 
728 
phospholipids 
- , unsaturated 750 
— , serum 750 
phosphorus 
- , bone biopsy 403 
- - , neutron activation 
analysis 403 
phosphorylation 
- , proteins 111 
— , carbon tetrachloride 
poisoning 111 
physical chemistry 
- , quantities and units 829 
pineal gland 
- , synchronization of cell func-
tion 763 
placenta 
- , aminopeptidases 631 
- , cystine aminopeptidase 631 
dehydroepiandrosterone 
metabolism 747 
- , proteins 821 
placental lactogen 748 
- , enzyme immunoassay 735 
plasma see also blood, serum 
- , adrenal steroid hormones 
740 
— , circadian variation 740 
— , episodic variation 740 
- , 5-androsten-3/3, 17/3-diol 
117 
a2-antiplasmin 221 
- , antipyrine® 817 
— , gas chromatography 
817 
- , antithrombin I I I 221 
- , bupivacaine 351 
- , cAMP 909 
— , after glycagon 909 
plasma see also blood, serum 
- , catecholamines 413, 431 
- - , conjugated 431 
— , determination 413 
, radioenzymatic 413 
- , colloid osmotic pressure 
233 
- , corticotropin 740 
— , circadian variation 740 
— , episodic variation 740 
Cortisol 740 
— , diurnal variation 740 
C-peptide 313 
- , C-reactive protein 701 
—, dehydroepiandrosterone 
117 
- , density 615 
— , and haemolysis 615 
- , dopamine 367 
- , enzymes 89 
— , IFCC methods 89 
- , epinephrine 367 
fibronectin 797, 893 
— , liver diseases 893 
- , 7-glutamyltransferase 237 
— , and ethanol 237 
HDL-cholesterol 737 
— , and thyroid state 737 
- , heparin 658 
— , clinical relevance 658 
— , determination 658 
- , insulin 313 
- , iron 714 
— , method comparison 714 
<x2-macroglobulin 221 
- , magnesium 257 
norepinephrine 367 
- , peptide hormones 731 
— , separation 731 
Phenazone 817 
- - , gas chromatography 817 
- , polyamines 157 
- , proinsulin 313 
- , protein 744 
— , variation 744 
- , proteins 615 
— , determination 615 
, oscillator technique 615 
- , renin 367 
- , 0-thromboglobulin 656 
— , clinical significance 656 
— , determination 656 
platelets 
- , adenosine nucleotides 712 
- , reference values 621 
- , tetrahydro-0-carboline 133 
- , tetrahydronorharmane 133 
- , thromboxane synthesis 708 
— , inhibition 708 
, by N-acetyl neuraminic 
acid 708 
plausibility 
- , intervals 694 
— , age 694 
— , sex 694 
plexus chorioideus 
- , lectin receptors 380 
podocytes 
glomerular 381 
— , and lectins 381 
Polyacrylamide gel electro-
phoresis 
- , sample preparation 23 
polyamines 
- , plasma 157 
— , determination 157 
- , urine 157, 698 
— , cancer patients 698 
— , determination 157 
polyarthritis, chronic 
- , N-acetylglucosaminidase 
53 
— , urine 53 
- , proteins 53 
— , urine 53 
, diselectrophoresis 53 
potassium 
- , urine 703 
practicability 78 
prealbumin 
- , cerebrospinal fluid 7, 245, 
746 
— , determination 245 
precision 69, 78, 433 
- , matrix effects 461 
- , method comparison 461 
prednisone 
- , leukemia treatment 690 
— , ATP 690 
pregnancy 
calcitonin 747 
- , complications therapy 748 
— , and oestriol 748 
- - , and placental lactogen 
748 
- - , and progesterone 748 
- , parathyrin 747 
phenylalanine 755 
— , metabolism 755 
- , progesterone 355 
— , urine 355 
pregnancy monitoring 
- , pregnancy-specific 0i-glyco-
protein 701 
pregnancy specific ßi-globulin 
821 
pregnancy-specific ß i -glyco-
protein 
- , enzyme immunoassay 701 
- , radioimmunoassay 701 
pregnancy monitoring 701 
--, tumour marker 701 
pressure 
- , colloid osmotic 233 
- , partial 829 
— , carbon dioxide 829 
- - , oxygen 829 
primidone 
- , serum 227 
— , determination 227 
processor 
- , specifications 947 
progesterone 
- , pregnancy 748 
- , radioimmunoassay 734 
- , urine 355 
— , determination 355 
progestine 
- , binding 724 
— , melanoma 724 
proinsulin 
- , plasma 313 
- , urine 313 
prolactin 
- , serum 867 
— , after insulin 867 
- - , after thyroliberin 867 
promegestone 
- , receptor binding 729 
prostate 
- , carcinoma 297 
— , phosphatase, acid 297 
- , phosphatase, acid 627, 669, 
681,682 
— , determination 627, 681, 
682 
, with indoxylphosphate 
682 
protease 
- , inhibitors 671 
— , in endotaxaemia 671 
proteases 
- , amniotic fluid 749 
protein 
- , cow's milk 715 
— , folate binding 715 
— , 5-methyltetrahydrofolate 
binding 715 
—, determination 501 
— , immunoturbidimetry 
501 
- , interleukin-2 inducing 716 
— , serum 716 
- , leukaemia serum 716 
— , folate binding 716 
- , malnutrition 287 
- , metabolism 901 
— , glomerula 901 
- , plasma 744 
— , variation 744 
- , synthesis 111 
— , liver 111 
, after carbon tetra-
chloride 111 
total 687, 696, 697 
— , determination 696, 697 
, method comparison 697 
— , fenoterol 687 
— , verapamil 687 
protein-A 
- , IgG binding 677 
- , macro enzyme binding 677 
protein binding 
- , clobazepam 209 
protein pattern 
cerebrospinal fluid 23 
— , and sample preparation 23 
proteins 
- , cerebrospinal fluid 123 
— , nephelometry 123 
- , lectin binding 382 
- , placental 821 
- , plasma 615 
— , determination 615 
, oscillator technique 615 
- , stabilization 684 
— , by heavy water 684 
- , urine 53 
- - , disc electrophoresis 53 
, value, diagnostic 53 
proteoglycans 
- , synthesis 684 
— , in liver cell injury 684 
pseudoCholinesterase 
- , and HDL-cholesterol 684 
purines 
- , metabolism 754 





- , requirements 861 
— , health care 861 
quality control 855, 861 
- , assessment of methods 78 
- , biotransformation enzymes 
775 
- , haematology 649 
- , internal 535 
- , principles 69, 78 
- , radioimmunoassay 215 
- , survey, external 183, 511 
— , Cortisol 183 
— , thyroxine 511 
— , triiodothyronine 511 
quality control 





— , hair root cells 672 
radioimmunoassay 
- , aldosterone 742 
- , 5-androsten-3/3, 170-diol 117 
- , anti-Factor V I I I clotting 
activity 711 
- , apolipoprotein A-I 917 
- , apolipoprotein A-II 917 
- , cAMP 732 
— , inhibition by EDTA 732 
- , chenodeoxycholic acid 491 
- , cholic acid 491 
- , confidence intervals 879 
creatine kinase-B 678, 679 
- , data 660 
— , computer processing 660 
- , dehydroepiandrosterone 
117,741 
- , evaluation 215, 879 
- , Factor VTII-related antigen 
711 
- , F-CB3 711 
- , fibrinopeptide-A 711 
- , homologous 789 
— , parathyrin 789 
- , 18-hydroxycorticosterone 742 
- , kallikrein 395 
- , magnetic solid-phase 706 
- , pepsinogens 688 
- , phosphatase, acid 681, 682 
- , pregnancy-specific ß\-glyco-
protein 701 
- , progesterone 734 
- , quality control 215 
--, parathyrin 739 
— , influence of the tracer 739 
- , solid phase 585 
— , parathyrin 585 
- , somatostatin 734 
- , standard curve 105 
- - , calculation 105 
- , standardization 659 
- , testosterone 741 
- , thyrotropin 807 
- - , method comparison 807 
- , thyroxine 571, 700 
— , separation system 700 




- , somatostatin 734 
rapid tests 
- , CSF diagnosis 7 
— , sensitivity 7 
rat 
- , glycosaminoglycans 279 
— , liver 279 
— , serum 279 
RBC 
—, reference values 621 
receptors 
cAMP 656 
- - , tissue 656 
, malignant 656 
- , glucocorticoid 655 
— , leukaemia cells 655 
- , oestrogen 653, 728 
— , capacity modulation 728 
, by phosphatidyl 
choline 728 
— , mammary carcinoma 653 
receptors 
steroid 654, 725, 726, 727, 
728, 729 
— , determination 725, 726, 
727, 728, 729 
— , endometrium 654 
— , stability 726 
- , studies 653 
— , principles 653 
reference material 
- , coagulation 744 
reference range 
- , glucose 745 
— , bivariate 745 
, CSF/Serum 745 
reference values 
- , aluminium 591 
— , serum 591 
- , children 713 
—,copper 713 
, serum 713 
, urine 713 
— , zinc 713 
, serum 713 
, urine 713 
- , haematology 621 
- , lactate dehydrogenase 305 
— , age dependency 305 
reliability 
- , criteria 197 
— , enzyme immunoassay 197 
renal damage 
- , tubular 53 
— , N-acetylglucosaminidase 
53 
, urine 53 
— , disc electrophoresis 53 
, urine proteins 53 
renin 
- , plasma 367 
— , exercise 367 
renin-angiotcnsin-aldosterone 
system 
- , fenoterol 687 
- , verapamil 687 
resorption 
- , magnesium 257 
reversed-phase chromato-
graphy 
- , peptide hormones 731 
ribosomes 
- , proteins 111 
— , in liver injury 111 
rifampicin 
- , and Cortisol 897 
— , blood 897 
of men 897 
- , and testosterone 897 
— , blood 897 
, of men 897 
risk populations 
- , identification 763 
— , enzyme tests 763 
sample 
- , preparation 23 
— , Polyacrylamide gel electro-
phoresis 23 
—, processor 692 
sampling 
- , specifications 947 




„Schneller Block11 693 
scintigraphy 
- , immune 821 
scoliosis 
- , in children 672 
- - , glycosaminoglycans 672 
screening 
- , cystinuria 303 
- , hypothyroidism 755, 807 
— , congenital 755, 807 
seminal plasma 
- , fibronectin 797 
septicaemia 
- , immune complex-like 
material 717 
serotonin 
- , synchronization of cell 
function 763 
serum see also blood, plasma 
- , albumin 96 
— , standard 96 
- , aluminium 591 
- - , emission spectral 
analysis 591 
- , antiepileptics 720 
— , enzyme immunoassay 
720 
— , gas chromatography 720 
- , bilirubin, total 27 
— , neonates 27 
, survey report 27 
- , carbamazepine 227 
- , carcinoembryonic antigen 
175 
- , calcitonin 747 
— , neonates 747 
— , pregnancy 747 
- , cefotaxime 719 
- , chenodeoxycholic acid 
491 
- , cholesterol 752 
- , choiic acid 491 
- , clobazepam 209 
- , copper 712, 713 
- - , determination 712 
-, reference values 713 
, children 713 
corticosteroid binding 
globulin 137 
- , Cortisol 183, 867 
— , after insulin 867 
— , quality control survey 
183 
— , after thyroliberin 876 
- , creatine kinase 675, 676, 
679 
—, Duchenne muscular 
dystrophy 675 
- - , isoenzymes 676, 679 
, acute myocardial 
infarction 676 
, acute craniocerebral 
damage 676 
- , creatinine 385, 423 
— , determination 385 
— , variation 423 
- , deacetylcefotaxime 719 
- , delipidation 917 
— , high density lipoproteins 
917 
— , apolipoproteins 917 
enzymes 89 
— , IFCC methods 89 
- , ethanol 722 
— , microdetermination 
722 
- , ethosuximide 339 
— , gas chromatography 
339 
fucosyltransferase 670 
— , tumour therapy moni-
toring 670 
serum see also blood, plasma 
- , glucose 49, 867 
— , after insulin 867 
— , after thyroliberin 867 
— , kinetic determination 49 
, hexokinase method 49 
- , glycosaminoglycans 279 
IgE 145 
- , immunoglobulines 718 
— , determination 718 
- , iron 147 
- , lipoproteins 749, 752, 753 
— , coronary heart disease 749 
- , <*2-macroglobulin 67, 671 
—, Dyggve-Melch ior- Clau sen 
syndrome 67 
- , magnesium 257 
- , methotrexate 169 
- - , enzyme immunoassay 169 
- , monoamine oxidase 921 
— , in hepatic fibrosis 921 
- , 5'-nucleotidase 333 
- , oestrogens 327 
- , parathyrin 747 
— , neonates 747 
— , pregnancy 747 
- , pepsinogens 688, 700 
— , kidney transplantation 
688 
- , phenobarbital 227 
- , phenytoin 227 
- , phospholipids 705 
— , unsaturated 750 
- , primidone 227 
- , prolactin 867 
— , after insulin 867 
— , after thyroliberin 867 
- , protein 716 
— , interleukin-2 inducing 
716 
- , sex hormone binding 
globulin 137 
- , sex hormones 737 
— , liver diseases 737 
- , sialyltransferase 271 
- , somatotropin 867 
- - , after insulin 867 
— , after thyroliberin 867 
- , standard 99 
— , IFCC 74/1 99 
- , thyroid hormones 737 
- - , liver diseases 737 
- , thyrotropin 755, 867 
- - , hypothyroidism 755 
, congenital 755 
- - , after insulin 867 
- - , after thyroliberin 867 
- , thyroxine 571 
— , radioimmunoassay 571 
- , triiodothyronine 571 
- - , radioimmunoassay 571 
- , urea 423 
— , variation 423 
- , uric acid 363,702, 745 
— , age dependency 745 
— , sex dependency 745 
- , valproate 339 
— , gas chromatography 339 
- , valproic acid 497 
— , gas chromatography 497 
- , zinc 712, 713 
— , determination 712 
- - , reference values 713 
, children 713 
sex 
of the child 611 
- - , and ^-glucuronidase 611 
, amniotic fluid 611 
- , plausibility intervals 694 
sex dependency 
- , uric acid 745 
— , serum 745 
sex-hormone binding globulin 
- , binding capacity 137 
— , in liver cirrhosis 137 
- , and 5a-dihydrotestosterone 
730 
- , and oestradiol 730 
- , and testosterone 730 
sex hormones 
- , serum 737 
— , liver diseases 737 
shock 
- , cardiogenic 675 
— , lactate dehydrogenase 
isoenzymes 675 
sialyltransferase 
- , inhibitors 271 
- , serum 271 
— , determination 271 
, interferences 271 
significance 
- , laboratory diagnosis 743 
sodium 
- , urine 703 
somatostatin 
- , catabolism 734 
- , radioimmunoassay 734 
- , radioreceptor assay 734 
somatotropin 
- , release 708 
— , in pancreatectomized 
men 708 
, and physical exercise 
708 
- , serum 867 
— , after insulin 867 
- - , after thyroliberin 867 
specifications 
- , analysers 947 
— , guidelines 947 
specificity 78 
spectrometers 
- , specifications 445 
— , listing 445 
spectrophotometry 
- , turbidity 149 
— , influence of 149 
spermidine 
- , determination 157 
spin label method 
- , application in haematology 
648 
spleen 
- , magnesium 257 
spline functions 105 
stability 
- , alanine aminotransferase 
521 
standard 
- , albumin 96 
- , serum 99 
— , IFCC 74/1 99 
standard curve 
- , radioimmunoassay 105 
— , calculation 105 
standardization 
- , radioimmunoassay 659 
standards 855 
statistical methods 69 
statistics 
- , problems 433 
— , in method comparison 
433 
stem cell population 
- , monitoring 648 




— , carcinogenesis 937 
extraction 355 
- , microassays 661 
- , receptor 725, 726, 727, 
728, 729 
— , determination 725, 726, 
727, 728, 729 
— , stability 726 
stimulation 
- , hypophysis 867 
stomach 
- , magnesium 257 
streptomycin 
- , and Cortisol 897 
— , blood 897 
, of men 897 
- , and testosterone 897 
— , blood 897 
, of men 897 
streptozotocin 901 
stress 
- , lead elimination 163 
substrates 
- , chromogenic 557, 631 
succinyl-ala-ala-val-4-nitro-
anilide 
- , elastase substrate 699 
sucrose 
- , interference 23 
— , protein pattern 23 
sulfate 
- , inorganic 651 
— , physical exercise 651 
survey report 
- , bilirubin, total 27 
- - , serum 27 
, neonates 27 
superoxide dismutase 
- , erythrocytes 771 
— , cord blood 771 
- - , maternal 771 
synchronization 
- , cell function 763 
synovial fluid 
- , fibronectin 797 
T-cell receptors 
- , antigen specific 1 
- - , detection 1 
- - , isolation 1 
T-lymphocytes 1 
dTTPase 
- , tumour marker 683 
Tamm-Horsfall glycoprotein 
- , kidney 376 
temperature 
- , enzyme assay 89 
terminology 
- , quality control 69 
testosterone 
- , blood 897 
— , of men 897 
, after rifampicin 897 
, after streptomycin 897 
- , enzyme immunoassay 661 
- , and sex-hormone binding 
globulin 730 
- , urine 741 
— , determination 741 
tetrahydro-/3-carboline 
- , platelets 129 
tetrahydronorharmane 
- , platelets 129 
thin layer chromatography 
- , androgens 117 
- , clobazepam 209 
thin layer chromatography 
- , metanephrine 413 
- , 3-methoxytyramine 413 
- , normetanephrine 413 
- , tetrahydronorharmane 129 
thrombocytes 
- , reference values 621 
/3-thromboglobulin 
plasma 656 
— , determination 656 
— , clinical significance 656 
thromboplastic activity 
- , arterial walls 545 
thrombosis 545 
thromboxane 
- , synthesis 708 
— , inhibition by N-acetyl 
neuraminic acid 708 
thyroid 
- , function 909 
— , and cAMP 909 
, plasma 909 
, after glucagon 909 
- , state 737 
— , and HDL-cholesterol 737 
- , hormones 257, 737, 738 
— , diabetogenic action 738 
— , magnesium metabolism 257 
— , serum 7 37 
, liver diseases 737 
thyroliberin 
- , neuroendocrine function 
test 867 
thyrotropin 
- , radioimmunoassay 807 
— , blood spot 807 
- , serum 755 
— , hypothyroidism 755 
, cut-off point 755 
thyroxine 
- , particle counting immuno-
assay 701 
quality control survey 511 
— , external 511 
- , radioimmunoassay 700 
— , separation system 700 
- , serum 571 
- - , radioimmunoassay 571 
tissue 
cAMP 656 
— , receptors 656 
tissue polypeptide antigen 
821 
tocolysis 
- , fenoterol 687 
- , verapamil 687 
transferrin 
- , determination 702 
- , monoferric 563 
— , isolation 563 
transplant rejection 
-, a i-antitrypsin 241 
— , serum 241 
transport 
- , magnesium 257 
Trinder reagent 
- , peroxidase assay 345 
triiodothyronine 
- , enzyme immunoassay 718 
- , quality control survey 511 
- - , external 511 
- , serum 571 
— , radioimmunoassay 571 
trypanosome 
- , characterization 383 
— , by lectins 383 
trypsin 
- , immunoreactive 763 
— , pancreatic diseases 763 
tuberculosis 
- , treatment 897 
— , and Cortisol 897 
— , and testosterone 897 
tumour 
- , fucosyltransferase 670 
- , marker 
— , carcinoembryonic antigen 
175 
— , diagnostic significance 
821 
— , dTTPase 683 




- , therapy monitoring 670 
turbidimetry 
- , proteins 245 
— , cerebrospinal fluid 245 
turbidity 
- , interference 149 





- , deproteinization 129 
— , glucose determination 129 
urea 
- , clearance 423 
- , determination 706 
— , kinetic methods 706 
- , physical exercise 651 
- , serum 423 
— , variation 423 
- , urine 423, 703 
— , variation 423 
uric acid 
- , determination 59 
— , enzymatic 59 
, interference 59 
, SMAC 363 
- , gestosis 749 
- , physical exercise 651 
- , serum 363, 702, 745 
— , age dependency 745 
— , high performance liquid 
chromatography 745 
— , method comparison 702 
— , sex dependency 745 
urine 
- , N-acetyH3-D-glucos-
aminidase 53, 687 
— , under amikacin therapy 
687 
— , under cisplatin therapy 
687 
— , determination 53 
, value, diagnostic 53 
- , adrenalin 567 
- , alanine aminopeptidase 687 
— , under amikacin therapy 
687 
— , under cisplatin therapy 
687 
- , aldosterone 742 
- , analysis 703 
— , Astra-8 Analyzer 703 
- , ascorbic acid 715 
— , determination 715 
, isotachophoresis 715 
- , ATP 686 
— , bioluminescence assay 686 
- , C-peptide 313 
- , cefotaxime 719 
- , chloride 703 
- , clobazepam 209 
urine 
-,copper 713 
— , reference values 713 
, children 713 
- , creatinine 385, 423, 703 
— , determination 385 
— , variation 423 
- , dehydroepiandrosterone 741 
- , desacetylcefotaxime 719 
- , dopamine 567 
- , enzymes 686 
— , kidney damage 686 
-,grücose 275, 703 
- , 18-hydroxycorticosterone 
742 
- , hydroxylysyl glycosides 
287 
- , hydroxyproline 287 
- , insulin 313 
- , kallikrein 395 
— , radioimmunoassay 395 
- , maltase 685 
- , 3-methoxy-4-hydroxy-
phenylglycol 579 
- - , gas chromatography 579 
- , Nl-methyl adenosine 696 
- , N7-methyl guanosine 696 
- , 3N-methylhistidine 755 
— , muscle catabolism 755 
- , noradrenalin 567 
- , oestrogens 731 
— , method comparison 731 
- , orotic acid 293 
- , peptide hormones 731 
- - , separation 731 
- , polyamines 157, 698 
- , potassium 703 
- , progesterone 355 
— , pregnancy 355 
- , proinsulin 313 
- , proteins 53 
— , disc electrophoresis 53 
, value, diagnostic 53 
- , protein, total 697 
- , sodium 703 
- , testosterone 741 
- , urea 423, 703 
— , variation 423 
- , urokinase 557 
- , zinc 713 
— , reference values 713 
, children 713 
urokinase 
- , urine 557 
valproate 
- , serum 339 
— , gas chromatography 339 
valproic acid 
- , gas chromatography 497 
value, diagnostic 
- , N-acetylglucosaminidase 53 
— , urine 53 
- , clinical-chemical tests 743 
- , disc electrophoresis 53 
— , proteins 53 
, urine 53 
values 
- , assigned 461, 855 
— , definition 461 
- , designated 855 
- , reference method 461 
variation 
- , circadian 740 
— , adrenal steroid hormones 
740 
, plasma 740 
— , corticotropin 740 
, plasma 740 
Variation 
- , diurnal 740 
- - , Cortisol 740 
, plasma 740 
, free 740 
, total 740 
- , episodic 740 
— , adrenal steroid hor-
mones 740 
, plasma 740 
- - , corticotropin 740 
, plasma 740 
longitudinal 423 
- - , creatinine 423 
, serum 423 
variation 
- , protein 744 
— , plasma 744 
verapamil 




- , leukaemia treatment 
690 









- , reference values 621 
water 
- , heavy 684, 747 
— , organ preservation 747 
— , protein stabilization 684 
zinc 
- , excretion 713 
zinc 
— , in rat bile 713 
, and glutathione deple-
tion 713 
, and paracetamol 713 
, and penicillamine 713 
- , serum 712 
— , determination 712 
, atomic absorption 
spectrometry 712 
, reference values 713 
, children 713 
- , urine 713 
— , reference values 713 
, children 713 
Wood, Bauer, Marschner and Scriba: External quality control survey for serum Cortisol 183 
J. Clin. Chem. Clin. Biochem. 
Vol. 18, 1980, pp. 183-192 
An External Quality Control Survey (EQCS) for Serum Cortisol 
By W. G. Wood,M. Bauer J. Marschner and P. C. Scriba 
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Klinische Chemie und Endokrinologie 
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Summary: The external quality control survey (EQCS) was based on those already published from this department 
(Marschner, I. et al. (1976) J. Clin. Chem. Clin. Biochem. 14, 345-351; Marschner, I. et al. (1974) Horm. Metab. Res. 
6, 293-296; Horn, K. et al. (1976) J. Clin. Chem. Clin. Biochem. 14, 353-360). Each participant received 20 sera 
sent in dry-ice by express post or airmail, together with a detailed questionnaire requesting assay details and raw data 
from his own standard curve as well as from the 20 samples. 
The data returned was transferred to punched cards and processed by computer (Siemens 404/3) using a modular 
system of programmes and sub-routines. 
The serum samples contained a hidden standard curve, samples for assay internal control and sera from suppression 
and stimulation tests. Possible crossreacting substances were added to 2 sera. Each participant received a detailed 
computer print-out with an explanatory letter and set of histograms for each serum sample with which he could check 
his performance against other participants, in particular those using the same kit as himself. 87 laboratories received 
the 20 samples for Cortisol assay. 64 laboratories returned data on the questionnaire sent, and of these, 49 sets of 
data could be fully worked out, the other 15 were only partly interpretable. Apart from laboratory-own methods, 
results from 9 different commercial kits were received. 21 participants had an intra-assay coefficient of variation 
under 5 %, 16 participants between 5 and 10 %. The minimum coefficient of variation for the 3 sera measured was 
0 % and the maximum 86 %. Coincidence of laboratory-own and hidden standard curves was only seen in 13 cases. 
Externer Ringversuch für Cortisol im Serum 
Zusammenfassung: Es wurde ein Ringversuch nach früherem Modell (Marschner, I. et al. (1976) J. Clin. Chem. Clin. 
Biochem. 14, 345-351; Marschner, I. et al. (1974) Horm. Metab. Res. 6, 293-296; Horn, K. et al. (1976) J. Clin. 
Chem. Clin. Biochem. 14, 353-360) durchgeführt. 
20 Seren wurden in Trockeneis verpackt und per Express an die Teilnehmer versandt. Jeder Teilnehmer erhielt einen 
Fragebogen, in dem alle Assay-Parameter sowie die Impulsraten der laboreigenen Standardkurve und die der 20 ge-
messenen Seren verlangt wurden. Die Ergebnisse wurden auf Lochkarten gestanzt, in einen Siemens 404/3 Computer 
eingelesen und ausgewertet. Die Auswertung erforderte etwa 30-35 Programme, die auf modularer Basis zusammen-
gestellt wurden. Die 20 Seren setzten sich zusammen aus einer versteckten Standardkurve, Proben mit kreuzreagieren-
den Substanzen, Seren von Stimulations- bzw. Suppressionstesten und anderen Poolseren. 
Jeder Teilnehmer erhielt einen Computerausdruck, einen ausführlichen Begleitbrief und einen Satz Histogramme, 
anhand derer er seine Leistung mit den anderen Teilnehmern vergleichen konnte. 
Die 20 Serumproben für die Cortisolbestimmung wurden an 87 Laboratorien versandt. 64 Laboratorien sandten 
Ergebnisse zurück, von denen 49 voll auswertbar und 15 nur teüweise auswertbar waren. Neben laboreigenen Me-
thoden wurden Ergebnisse von 9 kommerziellen Testbestecken eingesandt. 21 Teilnehmer hatten einen Variations-
koeffizienten (VK) unter 5 % und weitere 16 Teilnehmer einen VK zwischen 5 und 10 %. 
Der geringste VK betrug 0 % und der höchste VK 86 %. 
Eine Übereinstimmung der laboreigenen und der versteckten Standardkurve wurde nur in 13 Fällen erreicht. 
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Introduction 
The need for external and internal quality control in 
hormone assays is well recognised. In the Federal Re-
public of Germany, both external and internal quality-
control measures are laid down statutarily for clinical 
chemistry (1). EQCS for clinical chemical parameters 
and for several hormones are carried out by two authori-
sed bodies, namely the Deutsche Gesellschaft für Klinische 
Chemie (German Society for Clinical Chemistry) and 
INSTAND, Institut für Standardisierung und Dokumen-
tation. The hormone EQCS carried out by these two 
societies are not obligatory, thus leaving laboratories free 
to choose whether they participate or not. The hormone 
EQCS are carried out at regular intervals (3—4 times per 
year) and consist of two lyophilised samples sent by 
normal post to participants. An analysis of the results is 
then sent to each participating laboratory. Both the 
above organisers charge a small fee to participants to help 
cover costs involved. 
The disadvantage of such EQCS is the limited information 
which can be given regarding possible sources of error in 
the assay system of a participant and for this reason, an 
EQCS model was devised in this laboratory (2—4) to 
support the above surveys, whüe at the same time moni-
toring performance of commercial kits and self-construc-
ted assays. This system has been copied by others (5) and 
has been given the name the "Munich-Model" of EQCS 
(5). 
Preparation for the EQCS 
Choice of participants 
Letters of invitation were sent to active members of the Deutsche 
Gesellschaft für Endokrinologie and the Deutsche Gesellschaft für 
Klinische Chemie, to all commercial kit producers as well as to 
selected private and hospital laboratories. Each potential partici-
pant was asked whether he wished to take part in a quality 
control survey for Cortisol, and also to indicate his preference 
for the hormones which he would like to measure in the sub-
sequent 4 EQCS. From the replies, a list of participants as well 
as a priority list for the next EQCS was drawn up. All informa-
tion on participants in this and subsequent EQCS was then 
transferred to punched cards and stored away until needed. 
Sample preparation 
Serum samples from "special-interest" patients were pooled 
over a three month period to provide enough material for the 
EQCS. In addition, possible interfering substances, as well as sera 
from suppression and stimulation tests were collected. Table 1 
shows the composition of the 20 sera sent to each participant. The 
numbering of the samples was random. 
All samples were filtered through an asbestos filter (Seitz-filter, 
Bender and Hobein, D-8000 München) under pressure (5 Bar N 2 ) 
before being portioned into plastic cups (Eppendorf, D-2000 
Hamburg) in 1 ml lots. The filtration removed both bacteria and 
fibrin clots and rendered the sera clear and easy to pipette. All 
sera were then frozen at -25 °C until dispatch. 
The medium for the standard curve was made up as follows: 
40 g ' l " 1 Human Serum Albumin (Sigma - D-8011 Taufkirchen) 
20 g • l " 1 Human 7-globulins (Miles-Pentax - D-6000 Frankfurt 
a.M.) 
10 g • l " 1 Human 0-globutins (Miles-Pentax) 




C o n t e n t s 
1 Dexamethasone-suppression test pool serum 
2 Hidden standard curve - 0 nmol • l " 1 
3 Pregnancy pool serum - 21-42 weeks of gestation 
4 Intra-assay C.V. pool serum 
5 Hidden standard curve - 138 nmol • l " 1 
6 Hidden standard curve - 1725 nmol • l " 1 
7 Hidden standard curve - 448 nmol • l " 1 
8 Hidden standard curve - 276 nmol • l " 1 
9 Hidden standard curve - 46 nmol • l " 1 
10 Cushing's disease pool serum 
11 Hidden standard curve - 690 nmol • l " 1 
12 Serum 1 + corticosterone - 700 nmol • l " 1 
13 Stripped serum 
14 Intra-assay C.V. pool serum 
15 Serum 13 + serum 19 1 + 1 mixture 
16 Pool serum from 100 patients 
17 Intra-assay C.V. pool serum 
18 Serum 1 + 11-deoxycorticosterone - 725 nmol • I " 1 
19 Corticotropin stimulation test pool serum 
20 Pool serum - upper limit of normal range ( 0 9 ° 0 value) 
dissolved in Ringer solution (Fresenius - D-6380 Bad Homburg) 
This system gave a zero reading in three different assay systems, 
namely radioimmunoassay, competitive protein binding and 
fluorimetry. Corticosterone and 11-deoxycorticosterone were 
obtained from Fluka, D-7910 Neu-Ulm. 
Dispatch 
Samples were packed in expanded polystyrene squares and 
sealed with adhesive foil before being transferred to boxes of 
the same material (Febra, D-7129 Brackenheim) containing dry 
ice (5-7 kg). The boxes were then sent by express post or 
airmail to each participant together with a questionnaire and 
letter giving the last date for return of completed data forms. 
Questionnaire 
The points covered by the questionnaire were as follows: 
1. Name and address of participant. 
2. Whether the sera arrived still frozen. 
3. Method used in assaying the samples - including make of kit, 
label used, extraction procedure. 
4. Incubation scheme and volumes and constitution of reagents. 
5. Separation of bound and free hormone 
6. Counting apparatus and procedure 
7. Construction of standard curve with mathematical trans-
formation of data. 
8. Data concerning normal range, internal quality-control meas-
ures. 
9. Invitation to criticise the format of the questionnaire. 
10. Results from laboratory-own standard curve in terms of con-
centrations and counts. 
11. Cortisol contrations measured in the 20 sera together with 
counts. 
Data Processing 
Treatment of completed questionnaires 
All answers and data were coded and transferred to punched 
cards. The assay details were contained on three cards and the 
raw data from laboratory standard curve and measured sera on a 
further 27-32 cards, depending on the number of points used 
in the laboratory standard curve. 
Each participant was allotted a number known only to him and to 
the organisers. Numbers were allotted in the order in which the 
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Off-line 
I 1 
I Collection of raw data and transfer on to punch i 
i cards (statistical data, concentrations, standard I 
curve and count rates) J L 
Data storage 
Data transfer from punch cards to magnetic 
discs with concurrent preparation of data for 
standard curve construction. 
Main programme 1. 
a. Construction and print out of standard 
curves for each participant (spline function) 
b. Serum sample concentrations read off 
standard curves. 
c. Comparison of participant values with those 
read off the spline curves. 
d. Regression analysis of values given by parti-
cipant and those from the different standard 
and recovery curves. 
e. Storage of above data on magnetic discs. 
Main programme 2. 
a. Comparison of each participant's values with 
the mean of all participants' values. 
b. As a. above but for participants using the 
same kit. 
c. a. and b. were carried out for participant's 
own values and those read off the stand-
ardised and recovery curves. 
d. Print out of intra-assay c. v. from the stand-
ardised curve — from participant's own 
standards and count rates. 
Histogram plotting programme. 
Plotting of histograms from all 3 curves to give 
a visual representation of the distribution of 
participants for each sample. 
The participant could see at a glance where his 
values lay in respect to others both overall and 
to those using the same kit as himself. 
Each value was represented as a box containing 
both participant and kit numbers. 
Fig. 1. Data flow sheet and computer programme blocks for EQCS carried out in this laboratory. 
returned data were received. The assay method (or kit) was coded 
to allow a later comparison of performance between kits, and to 
compare different methods, for example, radioimmunoassay and 
competitive protein binding assays. 
Computer programme layout 
Figure 1 shows the layout of the computer programmes. The 
system was so devised that it could be used for subsequent 
EQCS with minimal modification. A Siemens 404/3 computer 
with paper-tape and punched-card reader was used. Data were 
stored on magnetic discs, each having a capacity of 3 MByte and 
the programme language was Fortran IV. 
The standard and recovery curves were constructed using a 
spline function as described by Reinsch (6) and modified for 
radioimmunoassay data by Marschner et al. (7). Histogrammes 
were drawn using a plotter connected on-line to the computer. 
Treatment of results 
After plotting the results and evaluation of data, the results from 
each participant were examined separately to see if either system-
atic or random errors were present. Figures 2a-2f show a 
copy of the 6-page computer print out. An explanatory letter 
was sent to each participant, containing an evaluation of 
laboratory performance together with constructive criticism 
for possible improvement where necessary, and a copy of 
histograms for all 20 samples. The participant was invited, i f 
he felt it necessary, to contact the organisers if any point was 
not clear, or if he needed help in reconstruction of his assay 
in order to obtain better results. 
Results 
Preliminary Data 
150 letters were sent to various laboratories in the 
Federal Republic of Germany who had indicated interest 
in taking part in hormone EQCS. 87 laboratories wished 
to take part in a Cortisol EQCS, of whom 64 returned 
either fully or partially completed questionnaires. From 
these 64 participants 49 were able to return fully-useable 
data and 15 partly-useable data. An analysis of laboratory 
type and returned data is shown in table 2. The majority 
of returned data was from University laboratories (50.0 %) 
with routine and research functions. This group also re-
turned the highest percentage (37.5 %) of incorrectly 
answered questionnaires. 
Tab. 2. Analysis of participating laboratories showing data 
returned. Laboratories are subdivised into groups. 
Type of laboratory No. of 
participants 
Data Data 
fully useable partly useable 
University clinic 
routine laboratories 32 20 12 
Local hospital 
routine laboratories 8 7 1 
Large private 
laboratories 8 6 2 
Small private 
laboratories 2 2 0 
Commercial kit 
producers or 
representatives 6 6 0 
Research laboratories 8 8 0 
Totals 64 49 15 
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TEILNEHMER NR. 1 
AUSWERTUNG OES CORTISOL-RINGVERSUCHS MAERZ-APRIL 1977 
AUC KU*V£N -U«06N MIT SPllNE-AppROXiMATION ERRECHNET. 
KURVE t : STANDARPtURVE NACH ANGABEN OES TEILNEHMERS, 
(FEHLTE ANGA&E ZUR UNSPEZ,BINOUNG, SO WURDE AUS PRUGRAMMTECHNISCHEN GRUENOEN N > 10 GESETZT) 
(EBENSO «URDE FUER FEHLENDE BÖ-WEKTE EIN PROGRAMMTECHNISCH BRAUCHBARER rfERT ANGENOMMEN) 
KURVE I I : VERSTECKTE STANDAROKURVE : NR.2 • 80 , STANDARDS i NR. 9 S 8 7 11 6 
MIT DEN VOM VERANSTALTER EINGESETZTEN KONZENTRATIONEN: 46 138 276 448 690 172* (NMOL/L) 
UND DEN VOM TEILNEHMER GEMESSEN* ZAEHLRATEN. 
KURVE I I I : VERSTECKTE STAN0A«0<URVE AUS DEN GLEICHEN PROBEN, ABER MIT DEN VOM TEILNEHMER GEMESSENEN 
KONZENTRATIONEN. (PkOZ.B1NOUNG BEZÜGEN AuF DAS B0 DER STANOAROKURVE) 
KONZENTRATIONEN, DIE FuER OlE KURVEN I I ODER I I I E P E NICHT ANSTEIGENDE KONZENTRATIONSFOLGE ERGEBEN HAETTfcN, 
• UPfEN NICHT KFMUECKSICHT IGT . 
K U« V E I 
STANOAROKOMZENTR. PROZ.(BU) S.D. 2*S.E.M. ORDINATE ZAEHLRATEN 
STANOARDLEERriERMBü) 100.00 2.496 2.23* 
2.872 
100.63 867*. 8740. 9072. 9 1 3 6 . 
2 7 . 6 NMOL/L 92.43 2.872 89.30 8105. 810*. 8142. 8601 . 
82.8 NMOL/L 68. 8* 2.108 2,108 68.47 636*. 6189. 6413. 6 0 2 3 . 
165.6 NMUL/L S3.4b 0,*37 0,*37 33.60 4979. 4903. 4920. 4 9 9 7 , 
276.0 N"UL/L 44.3* 3.066 3.066 43.82 4248. 4453. 4183. 3831 . 
690.0 N M Ü L / L 26. V9 1 .656 1,6*6 29.11 2993. 2973. 2878. 2687. 
16*6.0 NMOL/L 17.9* 1.488 1,488 1 7.90 2 0 * 8 . 1 769. 1996. 1978. 
3312.0 NMOL/L 10.27 1.381 1,381 10.30 1267. 1296. 1184, 1462. 
uNSPEZ.e iNDuf.G(N) 438. 316. 480. 507. 
KUhVE I I 
STANDARDKONZENTfc. 
STANOARDLEERtfEiiT(BO) 

























0 , 9 3 2 
1,497 
0 , 9 4 9 
1.061 
ZAEHLRATEN 
1 0 0 , 0 1 
7 3 . 7 9 
5 4 , 3 6 
4 0 , 9 0 
3 3 , 2 3 
2 5 , 1 8 
1 4 , 0 1 
9 1 3 1 . 
6 9 7 7 , 
5 3 1 7 . 
4 0 6 7 . 
3 5 8 5 . 
2 5 6 6 . 
1 7 5 9 . 













1 6 0 1 . 

















S.D. 2*S.E.K, ORDINATE ZAEHLRATEN 
1.420 1.639 1 0 3 , 9 7 9 1 3 1 . 9 3 2 5 . 9 1 0 6 , 
0 . 9 3 3 1,077 7 5 , 5 7 6 9 7 7 , 6 0 2 0 . 6 8 9 8 . 
1,133 1,308 5 7 , 1 3 5 3 1 7 . 5 1 4 8 . 5 1 5 5 . 
0 . 8 3 7 0 , 9 6 6 4 2 , 4 3 4 0 6 7 . 3 9 3 7 , 3 9 * 4 . 
1.344 1,5*2 3 6 , 0 7 3 5 8 5 . 3 3 5 9 . 3 4 3 4 , 
0.8*2 0 , 9 8 4 2 3 . 7 3 2 5 6 6 . 2 6 8 7 , 2 5 3 9 . 
0 . 953 1,100 1 4 , 5 9 1 7 5 9 , 1 6 5 4 , 1 6 0 1 . 
Fig. 2a. 
Fig. 2a-2f. A typical computer-print-out. 
Fig. 2a. The explanation of the 3 curves used, and the data used in constructing the curves. Curve I is from the data and counts of the 
participant's own standard curve; curve I I is the hidden standard curve using the organisers' assigned values and count-rates 
from the participant; curve I I I the values of the hidden standards measured by the participant and his own count-rates. Here 
B 0 is calculated as a percentage of the count-rates of the zero standard in curve I . 
Methods and kit codes 
43 participants used commercially available kits and 21 
their own methods. 48 participants used radioimmuno-
assay (RIA), 15 used competitive protein binding analysis 
(CPBA) and one fluorimetry to measure Cortisol. 36 partic-
ipants used 1 2 5 I , 20 used 3 H and 8 used 7 5 Se labelled 
tracer. The code used for the kits was: 
1. Clinical Assays (RIA - 1 2 5I-tracer) Travenol, D-8000 
München. 
2. Diagnostic Products Corporation (RIA - 1 2 5I-tracer) 
Biosigma, D-8000 München 
3. Amersham-Buchler (CPBA - 75Se-tracer) D-3300 Braun-
schweig. 
4. Corning (RIA - 1 2 5I-tracer) IMA, D-6300 Gießen 
5. Byk-Mallinckrodt (RIA - 1 2 5I-tracer) D-6057 Dietzen-
bach-Steinberg. 
6. Clinical Assays — Modified method — otherwise as Kit 1. 
7. CIS (CPBA - 1 2 5I-tracer) Isotopen Dienst West, 
D-6079 Sprendlingen. 
8. Lepetit (CPBA - 3H-tracer) Milan, Italy. 
9. New England Nuclear (RIA - 1 2 5I-tracer) D-6072 Drei-
eich. 
Own methods were not coded. 
J. Clin. Chem. Clin. Biochem. / Vol. 18, 1980 / No. 3 
Wood, Bauei, Marschner and Scriba: External quality control survey for serum Cortisol 187 
KUMVi ! : s s s s s KURVE 1! : 00000 
2 * S E * K I I ) : I 
KURVE I I I I 
2*SEM( I I I ) i 
I S S S S S S M I M t M S S S S S t 
100 I I I 0 0 0 •••••SSSiS 
T 00000000 ; ***»:iiS 
: 0 0 0 0 9 • SSS T 
: :0000 : SS T 
: ; 000: SST 
«0 • ; «00 T 
: : : 0 0 ««S 
: ; : 000 «SS 
: : : 00 
: : : 00 *S 
80 • : : o 
: : : 00 





















o w : 
OOSIi 
i t * 
tO$«t 
t 0 Tfl 
I 01 H i 
I 10 X I 




I IS $$S1 
T 
J.000 10.00 90.00 100,0 »00,0 1 0 0 0 , 5 0 0 0 . 1 0 0 0 0 . 
Fig. 2b. The print-out of the 3 curves. 
Results of sample analysis 
The content of the 20 serum samples is shown in table 1. 
The results of the more interesting samples are displayed 
in table 3. Difference in results from samples 2 and 13 
are due to the different matrix in the so-called cortisol-
free serum. Table 3 shows the results of samples either 
used for testing dilution or cross-reacting substances 
added to a serum sample. 
Samples 1,12 and 18 should be approximately the same 
if no cross-reactivity occurred between the antibody and 
corticosterone and 11-deoxycorticosterone, in the RIA, 
or if the binding proteins were specific for Cortisol in the 
CPBA. In all CPBA the cross-reaction in samples 12 and 
18 was high, reflecting the relatively unspecific nature of 
cortisol-binding-globulin (CBG) for these compounds. 
The kit CPBA gave on average lower cross reactivity than 
the "home-produced" CPBA. The one participant who 
used fluorimetry to measure Cortisol measured corti-
costerone, but not 11-deoxycorticosterone, showing 
that his extraction method was specific for 11-hydroxy 
steroids. 
The cross-reaction of the RIA-methods in samples 12 
and 18 was varied, and depended to some extent on the 
derivative used to raise the antiserum. The antibodies 
raised to C3-derivatives were more specific than those 
raised to C2i-derivatives. The kits showing no cross-
reactivity in both samples 12 and 18 (kits 2 and 6) were 
raised against C3-derivatives. 
The Cortisol measured in samples 2 and 13 was similar, 
although on average sample 13 (stripped serum) gave a 
lower value than sample 2 (protein matrix). Both sample 
2 and 13 gave significantly lower values than sample 1 
(dexamethasone suppression-test). 
In all cases where no interfering substances were present, 
all methods gave similar results seen in samples 13,15 
J. Clin. Chem. Clin. Biochem. / Vol. 18, 1980 / No. 3 
188 Wood, Bauer, Marschner and Scriba: External quality control survey for serum Cortisol 
T E I L N E H M E R NR. 1 
GEGENuEBERSTELLUNG DE K A N G A B E N OES TEILNEHMERS MIT DEN VON OEN KURVEN ABGELESENEN WERTEN 
fctfLAEuTEftUNG : ' L . T . ' : LESS THAN ( D I E PROBE WAR NICHT MESSBAR N I E D R I G ) 
'G.T.' : GREATER THAN ( D I E PROBE WAR NICHT MESSBAH HOCH) 
L I S T E DER WERTE 
A B G E L E S E N VON 
E I G E N E A NGABEN KURVE I K U R V E 11 KURVE I I I 
29.500 N M O L / L 29.524 N M O L / L 18.521 N M O L / L 23.913 N M O L / L 
1 .000 N M O L / L ZU N I E D R I G 1 .005 N M O L / L 1.319 N M O L / L 
1 00<». GGO N M O L / L 1003,050 N M O L / L 779,783 N M O L / L 1005.406 N M O L / L 
243.000 N M O L / L 243.006 N M O L / L 225,610 N M O L / L 249.821 N M O L / L 
1 4 4 . Ü Ü Ü N M O L / L 143.868 N M O L / L 136,897 N M O L / L 148.341 N M O L / L 
221S.000 N M Ü L / L 2209.160 N M O L / L 1705.085 N M O L / L 2204.61 7 N M O L / L 
441.000 N M O L / L 440,301 N M O L / L 412,407 N M O L / L 445.468 N M O L / L 
3US.000 NMOL/L 304,844 N M O L / L 281.607 N M O L / L 311.225 N M O L / L 
56.900 NMOL/L 56,493 N M O L / L 45,959 N M O L / L 53.905 N M O L / L 
1137.000 NMOL/L 1135,675 N M O L / L 866,161 N M O L / L 1137.471 N M O L / L 
085.000 N M O L / L 884,643 N M O L / L 706,274 N M O L / L 887.535 N M O L / L 
114.000 N M O L / L 113,472 N M O L / L 106,562 N M O L / L 115.940 N M O L / L 
1 2 . 1 0 J N M O L / L 10,474 N M O L / L 4.487 N M O L / L 6.56b N M O L / L 
262.000 NMOL/L 211,296 N M O L / L 197,947 N M O L / L 217.993 N M O L / L 
4 0 1 . O ü ü N M O L / L 401.805 N M O L / L 576,845 N M O L / L 407.303 N M O L / L 
1389,000 N M O L / L 1386,852 N M O L / L 1043,089 N M O L / L 1387.641 N M O L / L 
244.000 NMOL/L 242.902 N M O L / L 225,520 N M O L / L 249.718 N M O L / L 
273.000 N M O L / L 272.410 N M O L / L 251.657 N M O L / L 279,074 N M O L / L 
091,000 NMOL/L 687,002 N M O L / L 707,709 N M O L / L 889.884 N M O L / L 
662,000 N M O L / L 660,434 N M O L / L 570,901 N M O L / L 664,416 N M O L / L 
LINEARE REGRESSIONSRECHNUNG ZWISCHEN DEN AuF VERSCHIEDENE ART ERMITTELTEN WERTEN 
M(1 H I L F E OER REGRESSIONSRECHNUNG LASSEN SICH SYSTEMATISCHE UNTERSCHIEDE ZWISCHEN OEN UNTERSCHIEDLICH 
ERRECHNETEN WERTEN ERKENNEN,(IDEALFALL : KORR,KOE F F,«1 , R E G R , K u E F F , « 1 , A C H S E N A B S C H N I T T « 0 ) 
ERLAfcUTERUNG t DIE AN ERSTER STELLE GENANNTEN WERTE GEHEN ALS 
ALS ' V IN DIE RECHNUNG E I N . 
( ' E . A . - I * BEDEUTET Z.B. , DASS OlE EIGENEN ANGABEN MIT DEN AN KURVE 
KORRELIERT WüRdfcN) 
D I E AN / W E I T E R S T E L L E G E N A N N T E N WERTE 
A B G E L E S E N E N W E R T E N 
E.A.- 1 E.A.- I I E . A . - I I I I - I I I - I I I I I - I I I 
KORR.ftOEFF, • 1.000 0,996 1 ,000 0.998 1 .000 0.998 
RfcGR,KOEF F. • 1 .001 0.755 0.999 0,755 0.998 1.313 
A C N $ f c N A » U H N , ; •4.042 30.316 -0,447 33,385 3.602 •34,612 
ANZAHL wERTfc,: 19 19 19 19 19 20 
Fig. 2c. The 20 serum values read off the 3 curves compared with values given by the participant, together with regression data. 
Tab. 3. A comparison of results from 7 serum samples as analysed using different methods/kits. 
Method Own RIA Kit 1 Kit 2 Kit 4 Kit 5 Own CPBA Kit 3 Fluori-
metry 
No. of participants n =12 n= =7 n= =12 n =3 n
: = 3 n =6 n=8 n=l 
Tracer isotope 3 H 125j 12Sj 1 25, 125j 
7 5Se -
(nmol (nmol (nmol (nmol • r 1 (nmol • r 1 (nmol • r l ) (nmol • 1
 1 ) (nmol • f 1 ) 
X s X s X S X s X S X S X S X 
Serum No. 
1 17 17 33 10 43 27 56 l i 27 0.4 35 22 58 34 104 
12 156 131 78 36 71 21 991 79 119 33 817 299 306 39 2180 
18 429 305 304 29 57 11 334 99 369 111 714 220 426 76 108 
2 15 28 3.8 3.7 13 12 5.2 0.4 8.9 4.6 35 38 29 29 34 
13 11 14 2.9 2.2 20 7.5 0 0 0 0 22 23 18 23 106 
15 351 88 304 62 359 77 379 55 278 93 368 110 334 50 503 
19 663 136 638 136 721 82 706 148 577 245 687 201 685 106 965 
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TEILNEHMER NM. 1 
AUSARTUNG DfcS CO« T I SOL-w I NG V E R SUC H S MAERZ-APRlL 77 T E U 2 
IN OER NACHFOLGENDEN LISTE IST OER UNGEFAEHRE CORTISOL-GEHALT BZW, DIE HERSTELLUNG DER PROBEN AlfGEFuEHRT. 
OIE HIT 'STANOARO' BEZEICHNETEN PROBEN DIENTEN ZUR GEwlNNUMG OER 'VERSTECKTEN' STANOAROKURVEN . SIEHE TEIL 1 ) 
D I f MIT 'TEST' ODER 'POOL' BEZEICHNETEN PROBEN DIENTEN ZUR KONTROLLE OES ASSAV-V ERHALT ENS 
UNUM VERSCHIEDENEN BEDINGUNGEN. DIE SICH STOEREND AUSWIRKEN KONNTEN. 
IM EINZELNEN HABEN DIE PROBEN FOLGENDE BEOEUTUNG I 
PROBE 2 UNO 13 SOLLTEN BEIDE ALS 'CORTISOLFREI' ERMITTELT WERDEN. 
OIE PROBEN 4,14 UNO 17 WAREN GLEICH ( H * MITTLEREN BEREICH) UNO DIENTEN ZUR INTRA-ASSAV-QUALIT4ESKONTROLLE. 
DIE PROBEN 12 UNO 18 01ENTEN ZUR PRUEFUNG AUF EVTL, KREUZREAKTIONEN, 
SIE HATTEN DEN GLEICHEN CORTISOL-GEHALT wlE PROBE 1 , WAREN ABER MIT STOERSUBSTANZEN VERMISCHT. 
PftOttE 15 SOLLTE ETwA DEN MITTELWERT ZWISCHEN PROBE 13 UNO 19 ERGEBEN. 
DIE PROBE 16 DIENTE ZUR PRUEFUNG UNSPEZIFISCHER STOEREFF£KTE , 
1 TEST OEVAMETHASON SUPPRIMIERT 
2 STANDAHD 0 NMOL/L 
3 TEST SCHWANGERSCHAFT 2.HAELFTE 
4 POOL NORMALdEREICH 
5 STANOARO 138 NMOL/L 
6 STANOARO i 7 2 5 NMOL/L 
7 STANOARO 448 NMOL/L 
8 STANOARO 276 NMQL/L 
9 STANDARD 46 NMOL/L 
10 TEST CU$HING-SYNDROM 
11 STANDARD 690 NMOL/L 
12 TEST OCKAMETHASON • CORTI COSTERON 700 NMOL/L 
13 TEST 'STRIPPED SERUM* <0**ERT) 
14 POOL NORMALBERE ICH 
13 TfST ACTH • ' S T R I P P E D SERUM * 1|1 
16 TEST MISCHSERUM VON 100 PATIENTEN 
17 POOL NORMALBERE ICH 
18 TfST OEKAMETHASON • 11-OiSOXVCORTICOSTfRON 723 NMOL/L 
19 TEST ACTH-STIMULlfRT 
2U POOL GRENZwERT/ERHUEHT 
Fig. 2d. The composition of the 20 sera. 
and 19, where 15 lay, as expected midway between 13 
and 19. 
In contrast to an earlier EQCS for thyrotropin (2) the 
results from the hidden standard curve were not much 
better than those from the standardised laboratory-own 
curve. This is perhaps due to the fact that the antibodies 
used were raised against different cortisol-protein con-
jugates, that all methods involved a prior extraction/ 
denaturation step and the relative unspecific binding 
characteristics of CBG. The use of a non-ideal matrix in 
which the standard curve in the survey samples was set 
up had most probably little or no influence on the 
results when the assay conditions are examined. 
The results for sample 17 are shown in figures 3 a—3 c as 
constructed from laboratory results, from the standard-
ised laboratory result and from the hidden standard 
curve. These pictures emphasise what is written in the 
previous paragraph. 
Coincidence of standardised laboratory curve and 
hidden standard curve occurred in 28 cases (56 %). The 
regression equation as read off the laboratory own and 
standardised laboratory curve was better than y = a + 
(0.9 to 1.1) x in 36 cases (72 %), an index for the ability 
to read data from a standard curve. Within the same limits, 
the regression line between standardised laboratory 
curve and hidden recovery curve was identical in only 13 
cases (26 %), and serves as an index for the accuracy of 
the assay. 
The number of participants with an intra-assay coefficient 
of variation (CV) under 5% was 21 (33 %), between 5 
and 10%, 16(25%), between 10 and 15%, 7(11 %) and 
above 15 %, 20 (31 %). The minimum CV recorded was 
0 % and the maximum 86 %. 
Discussion 
The amount of data returned in the "Munich-Model" 
EQCS is enormous and it is difficult to extract only 
those data which give the maximum information to the 
participant. The visual aid effect of the standard and 
hidden standard curves show the participant at a glance 
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TEILNEHME* NR. 1 
SKENE ANGABEN 
N0. Irtft wERT : ALLE TEILNEHMER TEILNEHMER MIT IHREM KIT (NR 1 ) 
MITTELWERT s.o. 2 * S , 0 BEREICH MITTELWERT S . O . 2 « S . i 0 . - BEREICH 
1 29.50 3 7 . 2 0 1 5 . 9 8 5 . 2 4 6 9 , 1 6 3 3 . 1 8 1 0 . 0 8 1 3 . 0 1 5 3 . 3 5 
2 O . O U 2 5 , V 3 2 2 , 0 0 - 1 8 . 0 8 - 6 9 , 9 4 1 5 . 5 8 14.33 - 1 3 . 0 7 • 4 4 . 2 5 3 10U4.00 9 1 9 . 7 6 1 7 3 . 2 1 5 7 3 , 3 5 • 1 2 6 6 . 1 7 1 0 3 4 , 2 3 1 0 7 . 9 8 8 1 8 . 2 7 1 2 5 0 , 1 9 
4 2 4 3 . U 0 2 3 6 . 1 1 4 7 , 3 6 1 4 1 . 3 8 - 3 3 0 . 8 4 2 4 1 . 8 4 3 7 . 2 9 1 6 7 , 2 6 • 3 1 6 . 4 2 5 1 4 4 . 0 0 1 7 2 . 3 5 4 9 . 5 7 7 3 , 2 1 - 2 7 1 . 4 9 1 6 8 . 8 9 2 7 . 4 0 1 1 4 . 0 9 - 2 2 3 . 6 9 6 2 2 1 5 . 0 0 1726.75 3 6 3 , 9 8 9 9 * . 8 0 - 2 4 5 4 . 7 0 2 1 5 8 . 5 7 1 3 4 . 7 5 1 8 8 9 . 0 7 2 4 2 8 . 0 7 7 4 4 1 . 0 0 5 0 0 . 8 9 1 2 1 , 0 8 2 5 8 . 7 3 - 7 4 3 . 0 5 5 1 1 . 0 1 8 6 . 6 4 3 3 7 . 7 3 • 6 8 4 . 2 9 0 3 0 5 . 0 0 3 4 2 . 3 7 1 1 2 , 7 2 1 1 6 . 9 3 - 5 6 7 , 8 1 3 3 0 . 5 9 55.46 2 1 9 . 6 8 4 4 1 . 5 0 V 5 6 . V 0 6 2 . 3 1 3 2 , 7 5 - 3 , 1 8 - 1 2 7 . 0 0 5 8 , 5 1 2 5 . 2 1 8 , 1 0 - 1 0 6 . 9 2 10 1 1 3 7 . 0 0 8 7 8 , 2 4 1 4 8 . 5 4 5 8 1 . 1 6 • 1 1 7 5 . 3 2 9 8 7 . 0 7 1 2 1 , 4 6 7 4 4 , 1 4 1230.00 
1 1 O 0 5 . O O 7 Ö 3 . 9 5 2 0 6 . 1 2 3 7 1 . 7 1 - 1 1 9 6 , 1 9 8 2 7 . 1 7 1 1 0 . 1 6 6 0 6 , 8 6 1047.48 12 1 1 4 . 0 0 1 7 6 . 4 4 1 6 1 . 3 8 - 1 4 6 . 3 2 - 4 9 9 , 2 0 9 5 . 6 6 1 8 . 3 8 5 6 , 9 1 - 1 3 0 . 4 1 13 1 2 . 1 0 2 2 . 0 ? 1 6 . 1 1 - 1 0 , 1 6 - 5 4 , 3 0 1 0 . 3 8 4 , 0 4 2 , 2 9 1 0 . 4 7 1 4 2 6 2 . 0 0 2 3 4 , 3 1 5 4 . 3 3 1 2 5 . 6 5 • 3 4 2 , 9 7 2 3 2 . 0 4 5 1 . 3 3 1 2 9 . 3 8 5 5 4 . 7 0 
15 4 0 1 . 0 0 3 6 8 . 9 3 0 4 . 3 7 2 0 0 . 2 0 - 5 3 7 , 6 6 3 4 3 . 7 1 3 7 . 1 5 2 6 9 . 4 2 - 418.00 16 l i b * . 0 0 7 7 3 . 4 7 3 0 7 . 9 9 1 5 7 . 5 0 - 1309,44 1 2 1 6 . 0 8 1 9 4 . 2 3 8 2 7 . 6 2 • 1 6 0 4 . 5 4 1 7 2 4 4 . 0 0 2 3 6 . 1 4 6 1 .55 1 1 3 . 0 5 • 3 5 9 , 2 3 2 4 2 . 5 2 6 2 . 0 4 1 1 8 . 4 3 3 6 6 , 6 1 
16 2 7 3 . 0 0 2 V 4 . 1 3 2 0 4 , 0 2 - 1 1 3 . 9 1 • 7 0 2 , 1 7 3 6 4 . 4 3 5 8 . 6 9 2 4 7 , 0 5 • 4 6 1 , 8 1 
19 8 9 1 . 0 0 711,1,7 1 5 * . 1 5 4 1 4 . 1 6 • 1 0 3 0 . 7 0 7 6 3 . 7 8 1 7 9 . 9 3 4 0 3 . 9 1 1 1 2 3 . 6 5 
20 6 6 2 . 0 0 5 4 8 . 2 8 1 3 4 , 0 8 2 8 0 . 1 2 - 8 1 6 , 4 4 5 8 5 . 0 9 6 0 . 2 9 4 6 4 , 5 1 7 0 5 , 6 7 
I N T R A - A S S A V - V A R I A N ; AUS OEN PROBEN I 4 , 14 , 17 , 
M I T T E L W E R T * 2 4 V . o 7 S.O.* 1 0 . 6 9 3 V . K . » 
ABGELESEN VON KURVE I : 
NR. IHR wERT A L L E T E I L N E H M E R 
4 , 2 8 PftOZ, 
T E I L N E H M E R M I T IH R E M K I T ( N R 1 ) 
M I T T E L W E R T 2 * S . D . - B E R E I C H M I T T E L W E R T 2*S.O.-BEREICH 
1 2 9 . 5 2 3 2 . 8 0 16.31 - 3 . 8 1 - 6 9 , 4 1 2 5 . 4 5 9.84 5.77 4 5 . 1 3 • 2 0.00 2 3 , 5 0 22 . 9 8 - 2 2 . 4 5 - 6 9 . 4 5 1 1 . 3 7 9 , 6 6 - 7 , 9 6 - 3 0 . 7 0 3 1 G O 3 . 0 5 V 4 0 . 2 9 1 6 0 . 9 2 6 1 8 . 4 5 - 1 2 6 2 , 1 5 1 0 6 9 . 7 3 1 0 9 . 8 5 8 5 0 , 0 2 • 1 2 8 9 , 4 4 4 2 4 3 . 0 1 2 2 7 . 6 1 4 2 . 0 9 1 4 3 . 4 2 • 3 1 1 . 6 0 2 2 6 . 6 5 3 4 . 4 6 1 5 7 . 7 4 • 2 9 5 . 5 6 
5 1 4 3 . 6 7 1 5 5 . 8 6 44 . 6 9 6 6 , 4 9 - 245,23 2 5 3 6 . 2 5 1 4 7 , 2 0 4 1 . 4 2 6 4 . 3 5 - 2 3 0 , 0 5 6 2 2 0 9 . 1 6 1 8 6 0 . 6 2 3 3 6 . 7 1 1 1 8 3 . 4 1 - 2 1 3 2 . 1 9 2 0 8 . 7 8 1 7 1 4 . 6 4 • 2 5 4 9 , 7 4 7 4 4 0 . 3 0 465.33 1 0 8 . 7 1 2 6 7 , 9 2 - 7 0 2 . 7 4 5 0 7 , 1 1 6 8 . 5 2 3 3 0 . 0 7 - 6 8 4 . 1 5 8 5 0 4 . 6 4 3 0 7 . 3 5 8 9 . 7 6 1 2 7 . 8 2 - 4 6 6 . 6 6 3 2 0 . 1 0 5 5 . 3 7 2 0 9 , 3 7 - 4 3 0 . 6 3 9 5 6 . 4 9 5 2 . 2 6 2 7 . 0 8 - 1 , 8 9 - 1 0 6 , 4 5 5 1 . 5 5 2 8 . 7 1 -5.07 • 1 0 8 . 9 7 1 0 1 1 3 5 . 6 / 4 1 9 , 9 4 1 3 7 . 1 8 6 4 5 , 5 9 - 1 1 9 4 , 2 9 1 1 0 5 , 8 6 9 9 9 , 1 9 1 1 8 . 0 6 7 6 3 , 0 2 • 1 2 3 5 , 5 6 11 8 8 4 . 6 4 7 7 0 . 6 6 1 0 7 , 5 0 4 3 5 , 6 6 - 8 6 0 . 7 9 8 1 . 1 3 6 9 6 . 5 2 • 1 0 2 3 . 0 6 1 2 1 1 3 . 4 7 1 5 1 , 6 8 1 2 9 . 1 4 - 1 0 6 , 4 0 • 4 1 0 , 1 6 8 5 . 1 7 2 1 . 9 0 4 1 , 3 7 • 1 2 6 . 9 7 
13 1 0 . 4 7 1 7 . 0 4 1 5 . 7 3 • 1 4 , 4 5 - 4 6 , 5 1 6 , 3 9 4 . 2 9 • 2 . 2 0 - 1 4 , V 6 14 2 1 1 . 3 0 2 2 4 , 6 7 5 8 . 5 0 1 0 7 , 8 7 • 3 4 1 , 8 7 2 1 4 , 9 4 53.3? 1 0 6 . 2 1 • 5 2 1 . 6 ? 
15 4 0 1 . 0 1 4 5 5 . 5 6 9 4 . 3 0 1 6 6 . 9 7 • 5 4 4 . 1 5 
1 3 3 2 , 5 9 
3 5 1 , 3 9 7 4 , 6 9 202,02 - 5 0 0 . 7 6 • 16 1 3 6 6 . 8 5 7 4 6 . 6 5 2 V 2 . 8 8 1 6 1 . 0 7 - 1 2 6 4 , 5 1 1 7 2 . 4 6 9 1 9 , 4 0 • 1 6 0 9.22 17 2 4 2 . 9 0 2 5 1 . 4 t 7 3 . 7 6 8 3 . 9 0 - 3 7 8 . 9 4 2 0 9 , 5 6 33,61 1 4 2 , 3 4 • 2 7 6,76 16 2 7 2 . 4 1 2 9 5 . 5 6 2 0 9 . 2 9 • 1 2 3 , 0 0 - 7 1 4 , 1 6 555.30 6 5 . 2 9 226,73 • 4 8 1 , 6 7 1V 6 6 7 . 0 0 7 5 6 . 1 3 1 6 6 , 9 4 3 9 8 . 2 4 • 1 0 7 4 , 0 2 7 8 4 . 3 6 1 6 9 . 6 ? 4 4 3 . 0 2 • 1 1 2 3 . 7 0 
iU 6 6 0 . 4 3 5 4 6 . 0 2 1 1 9 . 2 2 5 0 9 . 3 9 • 7 8 2 , 4 5 6 1 2 . 4 6 9 7 . 4 1 4 1 7 , 6 3 • 6 0 7 . 2 9 
Fig. 2e. 
TEILNEHMER NR. 1 
ABGELESEN VON KURVE I I 
NR , IHR WERT : ALLE TEILNEHMER TEILNEHMER MIT IHREM K I T (NR 1 ) 
MITTELWERT S.O. 2 * S . D , « BEREICH MITTELWERT S.O. 2 - S . I D.-BEREICH 
1 1 8 , 5 2 2 7 , 1 0 1 5 . 9 3 - 4 , 7 6 5 8 , 9 6 1 9 , 3 « 1 2 . 1 8 - 4 . 9 8 4 3 . 7 4 
2 1 . 0 1 1 0 , 5 1 1 0 , 9 5 - 1 1 , 3 9 - 3 2 . 4 1 3 . 8 0 3 . 6 9 •3,5V • 1 1 . 1 9 3 7 7 9 . 7 8 8 3 7 , 1 6 1 8 6 . 8 9 4 6 3 , 3 7 - 1 2 1 0 , 9 5 8 4 3 . 5 4 8 9 . 5 1 6 6 4 . 5 2 1 0 2 2 . 5 6 4 2 2 5 . 6 1 1 8 7 , 0 2 41 .80 1 0 3 . 4 3 • 2 7 0 . 6 1 1 9 8 . 4 9 3 6 . 4 2 1 2 5 . 6 4 • 2 7 1 . 3 4 
5 1 3 6 . 9 0 1 3 5 , 7 3 7.V5 1 1 9 , 8 3 - 1 5 1 , 6 3 1 3 5 , 1 5 1 2 . 4 0 1 1 0 . 3 6 • 1 5 9 . 9 4 6 1 7 0 5 . 0 8 1 7 0 4 . 3 8 2 8 . 6 4 1 6 4 7 . 1 0 • 1 7 6 1 , 6 6 1 7 1 2 , 2 1 8.03 1 6 9 6 . 1 4 1 7 2 8 . 2 « 
7 4 1 2 . 4 1 4 4 4 . 0 2 1 9 , 0 3 4 0 5 , 9 7 • 4 8 2 , 0 7 4 2 6 . 1 2 2 8 . 7 7 3 6 8 . 5 9 4 9 5 . 6 5 
8 2 6 1 . 6 1 2 7 0 , 6 6 2 3 . 5 9 2 2 3 . 4 8 - 3 1 7 , 8 4 2 7 2 . 6 0 1 6 . 6 4 2 3 9 . 3 2 • 3 0 5 . « 6 9 4 S . 9 6 4 1 , 3 9 5.56 3 0 , 2 6 • 5 2 , 5 2 4 6 , 7 2 1 3 . 1 6 2 0 . 4 0 • 7 3 . 0 4 
10 6 6 6 . 1 6 8 3 0 . 2 7 1 2 7 . 6 1 5 7 5 . 0 5 • 1 0 8 5 , 4 9 7 9 7 . 6 3 5 3 . 5 4 6 9 0 . 5 4 • 9 0 4 . 7 2 
1 1 7 0 6 . 2 7 7 0 2 , 8 6 3 3 . 4 2 6 3 6 , 0 4 - 7 6 9 , 7 2 6 9 5 , 3 0 3 8 . 3 7 6 1 6 . 5 6 • 7 7 2 . 0 4 12 1 0 6 , 5 6 1 5 2 . 1 4 1 7 3 , 8 2 - 1 9 5 , 5 0 • 4 9 9 , 7 8 7 8 , 2 8 3 5 . 9 7 6 . 3 5 1 5 0 . 2 1 
13 4 . 4 9 1 6 , 1 8 9 . 0 8 - 1 , 9 8 - 3 4 , 3 4 2 , 8 9 2 . 2 6 - 1 , 6 3 • 7 , 4 1 14 1 9 7 . 9 5 1 8 3 , 9 3 3 6 . 7 5 1 1 0 , 4 4 • 2 5 7 , 4 2 1 9 0 , 2 2 4 0 . 7 4 1 0 « . 7 4 2 7 1 . 7 0 
15 3 7 6 . 8 4 3 2 4 , 6 6 7 7 . 1 2 1 7 0 , 6 3 - 4 7 9 . 0 9 3 0 3 , 7 3 6 2 . 3 4 1 7 9 . 0 5 • 4 2 8 . 4 1 1 6 1 0 4 3 . 0 9 7 2 3 , 6 4 2 7 0 , 3 7 1 8 2 . 8 9 - 1 2 6 4 . 3 9 9 7 9 , 6 8 1 0 6 . 1 0 7 6 7 . 4 9 • 1 1 9 1 . 8 7 17 2 2 5 . 5 2 1 9 3 . 4 0 4 5 , 2 5 1 0 2 , 9 0 - 2 8 3 . 9 0 2 0 2 , 6 4 4 6 . 0 6 1 1 0 . 4 7 • 2 9 4 . « 1 1 d 2 5 1 . 6 6 2 5 6 . 2 2 1 8 0 . 3 1 • 1 0 4 , 4 0 - 6 1 6 , 8 4 3 0 3 , 8 0 2 8 . 7 0 2 4 6 . 4 0 • 3 6 1 . 2 0 19 7 0 7 , 7 1 6 7 2 , 4 4 1 2 4 , o l 4 2 3 , 2 1 • 9 2 1 . 6 7 6 5 8 , 0 4 1 3 5 . 9 0 3 6 6 . 2 5 9 0 9 . 8 3 
2 0 5 7 0 . 9 0 4 9 5 . 3 5 61 ,64 3 3 2 . 0 7 • 6 5 8 , 6 3 4 8 5 , 6 8 5 1 . 5 0 3 8 2 . 6 9 - 5 8 8 . 6 7 
ZE1CHEMERKLAERUN6 : 
' • ' : WERT LIEGT AUSSERHALB OES 2*S.O.-BEREICHS ALLER TEILNEHMER, 
* • « ' : WERT WAR NICHT MESSBAR, 
Fig. 2f. 
Fig. 2e-2f. Values determined by the participant compared with values obtained by other participants using the same kit, and read 
off the participant's standard curve, the standardised (curve I) and the recovery (curve II) curves. The mean, standard 
deviation (S) and ± 2S ranges are given. 
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Fig. 3a-3c. The distribution of sample 17 (pool serum) from results given by the participant (fig. 3a), read off the standardised 
curve (fig. 3b) and from the hidden recovery curve (fig. 3c). The abscissa values are mean ± 3S range. The figures in the 
boxes are: lower left, participant number and upper right, kit number. Values lying outside the ± 3S range are shown 
on the extreme left and right of the histograms. 
if his assay is in order or not, although it must be 
stated that this is only strictly true for this one assay. 
This is in itself a disadvantage of the "Munich-Model" 
EQCS, which can only perform a spot-check on how a 
laboratory performs. This information is very im-
portant, especially in a country in which a large number 
of commercial kits are used. Changes in protocol, anti-
body, and tracer are not infrequent, and these can give 
rise to different results as seen in the comparison 
between kits 1 and 6 in this survey where new anti-
body, tracer and protocol considerably reduced the 
cross reactivity between 11-deoxycorticosterone and 
Cortisol. 
Another disadvantage of this system is its time-con-
sumption and its limitation to one, or at the most two 
components. This means that the same component 
cannot be repeated inside a 2-year period unless it is 
carried out by an institute specially designed to per-
form such quality control surveys. A few examples 
will make this more clear. The data from each partic-
ipant is transferred to between 30 and 35 punched 
cards (20 for the samples, 3 for the assay data and 
between 7 and 12 for the laboratory-own standard 
curve, including total counts and unspecific binding). 
The modification of the computer programmes has 
been minimised by the modular construction used, 
but around 100 punched cards are needed for the 
headings and serum composition, together with 20 
cards for each kit, containing mean and s.d. for each 
sample, and 60 cards containing sample number mean 
and s.d. for the histograms. The first 100 text-cards 
must be written by band, the latter 80 data cards are 
punched by commands from the computer. Each 
participant's printout of 6 pages took approximately 
3V2 minutes, most of this time being spent on the 
curve plotting, and each histogramme — in this EQCS 
— took between 10 and 11 minutes. Together with 
the photo-copying time needed so that each participant 
received the 20 histograms for the samples and an ex-
ample read from the standardised and hidden standard 
curve, one can begin to appreciate the real time needed — 
simply for sending the results back to each participant. 
As can be seen, this type of survey must be coupled to a 
regular 2 or 3 sample EQCS, which are at present run in 
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many countries, together with a continuous and rigorous 
laboratory internal quality control scheme. 
Another interesting point in the "Munich-Model" is the 
provision of correlation data between own results and 
those from the standardised and hidden standard curves. 
Here, it is very easy to see if errors which have arisen are 
of a methodological or random nature. For example a 
good correlation coefficient with a regression line slope 
widely deviating from 1.0 points to a methodological 
error (perhaps wrong dilution of standards) whereas a 
bad correlation coefficient indicates a non-optimal assay 
system. 
This type of EQCS has had a positive spin-off effect, that 
of monitoring the quality of commercial kits, without 
having to do anything except send the results to each 
participant. The effects of this, and of earlier EQCS from 
this laboratory (2) have led to a subsequent improvement 
of methodology and quality in commercial kits, and this 
method of "automatic-policing" is far more effective and 
much cheaper and quicker than legislative measures, which 
must be constantly updated to keep in touch with a 
rapidly moving field such as hormone analysis. 
The two-way contact opened up between kit-producers 
and organisers in this type of EQCS has led to a positive 
dialogue often resulting in improvement in kit-perform-
ance by optimation of methodology, thus paving the 
way for comparable results between different kits, a goal 
which must be attempted, especially for peptide and 
Proteohormones. That this state of affairs is by no means 
achieved even for a small molecule like Cortisol, can be 
seen by the wide variation in individual results and the 
relatively low coincidence of hidden and laboratory-own 
standard curves (26 %). The use of non-specific methods, 
here the CPB assays, show in their high cross-reactivity 
with closely related compounds, that many laboratories 
still use techniques which have long since been superseded 
by more modern technology - in this case RIA and 
125I-labelling, which give remarkably good results and 
are to be recommended, at least until the next gener-
ation of tests has been developed and proofed. 
The participant, for relatively little cost and work-load, 
receives a large amount of data, with which he can ex-
amine his method for faults, if such have arisen, and with 
which he can compare his performance with other methods 
and participants. The complete anonymity of participants, 
reduces the inhibition to make contact with the organisers 
should a participant require help, which is a very important 
point. To conclude, although these EQCS are laborious, 
they provide enough positive influence on the current 
state of hormone assays to warrant their continuance. 
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